QUARTERLY REPORT

Q3 2026 — Form 10-Q

Q3 2026PDF · 55 pages746 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 2026
or
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Commission File Number 1-16411
NORTHROP GRUMMAN CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 	80-0640649
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2980 Fairview Park Drive
Falls Church, Virginia 	22042
(Address of principal executive offices) 	(Zip Code)
(703) 280-2900
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock 	NOC 	New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth
company” in Rule 12b-2 of the Exchange Act:
Large Accelerated Filer ☒ Accelerated Filer ☐
Non-accelerated Filer ☐ Smaller Reporting Company ☐
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of October 15, 2026, 142,064,489 shares of common stock were outstanding.

-- 1 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
TABLE OF CONTENTS
Page
PART I – FINANCIAL INFORMATION
Item 1. 	Financial Statements (Unaudited)
Condensed Consolidated Statements of Earnings and Comprehensive Income 	1
Condensed Consolidated Statements of Financial Position 	2
Condensed Consolidated Statements of Cash Flows 	3
Condensed Consolidated Statements of Changes in Shareholders’ Equity 	4
Notes to Condensed Consolidated Financial Statements
1. Summary of Significant Accounting Policies 	5
2. Earnings Per Share, Share Repurchases and Dividends on Common Stock 	8
3. Inventoried Costs, Net 	8
4. Income Taxes 	9
5. Fair Value of Financial Instruments 	9
6. Investigations, Claims and Litigation 	11
7. Commitments and Contingencies 	11
8. Retirement Benefits 	13
9. Stock Compensation Plans and Other Compensation Arrangements 	13
10. Segment Information 	14
Report of Independent Registered Public Accounting Firm 	21
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview 	22
Consolidated Operating Results 	25
Segment Operating Results 	27
Product and Service Analysis 	31
Backlog 	32
Liquidity and Capital Resources 	32
Critical Accounting Policies, Estimates and Judgments 	34
Accounting Standards Updates 	34
Forward-Looking Statements and Projections 	34
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	35
Item 4. 	Controls and Procedures 	36
PART II – OTHER INFORMATION
Item 1. 	Legal Proceedings 	37
Item 1A. 	Risk Factors 	37
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	37
Item 5. 	Other Information 	37
Item 6. 	Exhibits 	38
Signatures 	39
i

-- 2 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME (Unaudited)
Three Months Ended September
30
Nine Months Ended September
30
$ in millions, except per share amounts 	2026 	2025 	2026 	2025
Sales
Product 	$ 	9,098 $ 	8,369 $ 	25,864 $ 	24,148
Service 	2,024 	2,054 	6,015 	6,094
Total sales 	11,122 	10,423 	31,879 	30,242
Operating costs and expenses
Product 	7,198 	6,631 	20,786 	19,523
Service 	1,572 	1,565 	4,660 	4,702
General and administrative expenses 	1,083 	985 	3,079 	3,008
Total operating costs and expenses 	9,853 	9,181 	28,525 	27,233
Gain on sale of business 	— 	— 	— 	231
Operating income 	1,269 	1,242 	3,354 	3,240
Other (expense) income
Interest expense 	(158) 	(161) 	(481) 	(490)
Non-operating FAS pension benefit 	167 	136 	499 	403
Other, net 	20 	106 	124 	175
Earnings before income taxes 	1,298 	1,323 	3,496 	3,328
Federal and foreign income tax expense 	174 	223 	403 	573
Net earnings 	$ 	1,124 $ 	1,100 $ 	3,093 $ 	2,755
Basic earnings per share 	$ 	7.91 $ 	7.69 $ 	21.77 $ 	19.16
Weighted-average common shares outstanding, in millions 	142.1 	143.1 	142.1 	143.8
Diluted earnings per share 	$ 	7.89 $ 	7.67 $ 	21.72 $ 	19.12
Weighted-average diluted shares outstanding, in millions 	142.4 	143.5 	142.4 	144.1
Net earnings (from above) 	$ 	1,124 $ 	1,100 $ 	3,093 $ 	2,755
Other comprehensive income (loss), net of tax
Change in cumulative translation adjustment 	2 	2 	— 	11
Change in other, net 	— 	(1) 	(6) 	18
Other comprehensive income (loss), net of tax 	2 	1 	(6) 	29
Comprehensive income 	$ 	1,126 $ 	1,101 $ 	3,087 $ 	2,784
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
-1-

-- 3 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(Unaudited)
$ in millions, except par value 	September 30, 2026 December 31, 2025
Assets
Cash and cash equivalents 	$ 	3,744 $ 	4,403
Accounts receivable, net 	2,080 	1,375
Unbilled receivables, net 	7,899 	6,544
Inventoried costs, net 	1,361 	1,309
Prepaid expenses and other current assets 	1,893 	1,656
Total current assets 	16,977 	15,287
Property, plant and equipment, net of accumulated depreciation of $10,306 for 2026 and $9,648 for 2025 	10,461 	10,972
Operating lease right-of-use assets 	2,182 	1,859
Goodwill 	17,440 	17,437
Deferred tax assets 	488 	1,051
Pension and other postretirement benefit plan assets 	3,447 	3,167
Other non-current assets 	1,502 	1,604
Total assets 	$ 	52,497 $ 	51,377
Liabilities
Trade accounts payable 	$ 	3,281 $ 	3,240
Accrued employee compensation 	2,039 	2,309
Advance payments and billings in excess of costs incurred 	3,838 	4,086
Other current liabilities 	4,595 	4,247
Total current liabilities 	13,753 	13,882
Long-term debt, net of current portion of $764 for 2026 and $534 for 2025 	14,433 	15,162
Pension and other postretirement benefit plan liabilities 	1,076 	1,110
Operating lease liabilities 	2,202 	1,857
Other non-current liabilities 	2,350 	2,692
Total liabilities 	33,814 	34,703
Commitments and contingencies (Note 7)
Shareholders’ equity
Preferred stock, $1 par value; 10,000,000 shares authorized; no shares issued and outstanding 	— 	—
Common stock, $1 par value; 800,000,000 shares authorized; issued and outstanding: 2026—142,064,132
and 2025—141,997,194 	142 	142
Paid-in capital 	63 	—
Retained earnings 	18,610 	16,658
Accumulated other comprehensive loss 	(132) 	(126)
Total shareholders’ equity 	18,683 	16,674
Total liabilities and shareholders’ equity 	$ 	52,497 $ 	51,377
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
-2-

-- 4 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended September
30
$ in millions 	2026 	2025
Operating activities
Net earnings 	$ 	3,093 $ 	2,755
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization 	1,118 	1,066
Stock-based compensation 	75 	65
Deferred income taxes 	651 	344
B-21 loss provision 	— 	477
Gain on sale of business 	— 	(231)
Net periodic pension and OPB income 	(361) 	(256)
Pension and OPB contributions 	(92) 	(94)
Changes in assets and liabilities:
Accounts receivable, net 	(705) 	(716)
Unbilled receivables, net 	(1,177) 	(1,240)
Inventoried costs, net 	(65) 	(179)
Prepaid expenses and other assets 	55 	(29)
Trade accounts payable 	41 	203
Advance payments and billings in excess of costs incurred 	(248) 	(505)
Other liabilities 	(868) 	(340)
Income taxes payable, net 	(125) 	(421)
Other operating activities 	(23) 	(39)
Net cash provided by operating activities 	1,369 	860
Investing activities
Capital expenditures 	(775) 	(788)
Proceeds from sale of equipment to a customer 	371 	—
Proceeds from sale of investment 	107 	—
Divestiture of training services business 	— 	333
Other investing activities 	(17) 	(36)
Net cash used in investing activities 	(314) 	(491)
Financing activities
Net proceeds from issuance of long-term debt 	— 	998
Payments of long-term debt 	(527) 	(1,500)
Common stock repurchases 	(68) 	(1,168)
Cash dividends paid 	(1,035) 	(964)
Payments of employee taxes withheld from share-based awards 	(58) 	(38)
Other financing activities 	(26) 	(93)
Net cash used in financing activities 	(1,714) 	(2,765)
Decrease in cash and cash equivalents 	(659) 	(2,396)
Cash and cash equivalents, beginning of year 	4,403 	4,353
Cash and cash equivalents, end of period 	$ 	3,744 $ 	1,957
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
-3-

-- 5 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(Unaudited)
Three Months Ended September
30
Nine Months Ended September
30
$ in millions, except per share amounts 	2026 	2025 	2026 	2025
Common stock
Beginning of period 	$ 	142 $ 	143 $ 	142 $ 	145
Common stock repurchased 	— 	— 	— 	(2)
End of period 	142 	143 	142 	143
Paid-in capital
Beginning of period 	37 	— 	— 	—
Stock compensation 	26 	— 	63 	—
End of period 	63 	— 	63 	—
Retained earnings
Beginning of period 	17,839 	15,452 	16,658 	15,297
Common stock repurchased 	— 	(278) 	(63) 	(1,150)
Net earnings 	1,124 	1,100 	3,093 	2,755
Dividends declared 	(353) 	(332) 	(1,034) 	(963)
Stock compensation 	— 	26 	(44) 	29
End of period 	18,610 	15,968 	18,610 	15,968
Accumulated other comprehensive loss
Beginning of period 	(134) 	(124) 	(126) 	(152)
Other comprehensive income (loss), net of tax 	2 	1 	(6) 	29
End of period 	(132) 	(123) 	(132) 	(123)
Total shareholders’ equity 	$ 	18,683 $ 	15,988 $ 	18,683 $ 	15,988
Cash dividends declared per share 	$ 	2.47 $ 	2.31 $ 	7.25 $ 	6.68
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
-4-

-- 6 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation and Reporting
These unaudited condensed consolidated financial statements (the “financial statements”) include the accounts of Northrop Grumman Corporation and its
subsidiaries and joint ventures or other investments for which we consolidate the financial results (herein referred to as “Northrop Grumman,” the
“company,” “we,” “us,” or “our”). Intercompany accounts, transactions and profits are eliminated in consolidation. Investments in equity securities and
joint ventures where the company has significant influence, but not control, are accounted for using the equity method.
On May 24, 2025 (the “Divestiture date”), the company completed its previously announced sale of substantially all of the Immersive Mission Solutions
(IMS) operating unit of Defense Systems (the “training services” business or “divestiture”) for $333 million in cash and recorded a pre-tax gain on sale of
$231 million. IMS is a provider of mission training and satellite ground network communications software for U.S. government customers. 2025 operating
results include sales and operating income for the training services business prior to the Divestiture date.
The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP” or “FAS”) and
in accordance with the rules of the Securities and Exchange Commission (SEC) for interim reporting. The financial statements include adjustments of a
normal recurring nature considered necessary by management for a fair presentation of the company’s unaudited condensed consolidated financial position,
results of operations and cash flows. For classification of certain current assets and liabilities, we consider the duration of our customer contracts when
defining our operating cycle, which is generally longer than one year.
During the fourth quarter of 2025, we modified our presentation of the changes in liabilities in the operating cash flow section of the consolidated statement
of cash flows by disaggregating Accounts payable and other liabilities into three separate line items: Accounts payable, Advance payments and billings in
excess of costs incurred, and Other liabilities. Prior period amounts have been conformed to the current period presentation. The modified presentation does
not impact previously reported cash provided by operating activities.
Results reported in the financial statements are not necessarily indicative of results that may be expected for the entire year. The financial statements should
be read in conjunction with the information contained in the company’s 2025 Annual Report on Form 10-K.
Quarterly information is labeled using a calendar convention; that is, first quarter is consistently labeled as ending on March 31, second quarter as ending
on June 30 and third quarter as ending on September 30. It is the company’s long-standing practice to establish actual interim closing dates using a “fiscal”
calendar, in which we close our books on a Friday near these quarter-end dates in order to normalize the potentially disruptive effects of quarterly closings
on business processes. This practice is only used at interim periods within a reporting year.
Accounting Estimates
Preparation of the financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and
the disclosure of contingencies at the date of the financial statements, as well as the reported amounts of sales and expenses during the reporting period.
Estimates have been prepared using the most current and best available information; however, actual results could differ materially from those estimates.
Revenue Recognition
Contract Estimates
Contract sales may include estimates of variable consideration, including cost or performance incentives (such as award and incentive fees), un-priced
change orders, requests for equitable adjustment (REAs) and contract claims. Variable consideration is included in total estimated sales to the extent it is
probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable
consideration is subsequently resolved. We estimate variable consideration as the most likely amount to which we expect to be entitled.
We recognize changes in estimated contract sales or costs and the resulting changes in contract profit on a cumulative basis. Net estimate-at-completion
(EAC) adjustments represent the cumulative effect of the changes on current and prior periods; sales and operating margins in future periods are recognized
as if the revised estimates had been used since contract inception. If it is determined that a loss is expected to result on an individual performance
-5-

-- 7 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
obligation, the entire amount of the estimable future loss, including an allocation of general and administrative (G&A) cost, is charged against income in
the period the loss is identified.
B-21 Program
The company has previously recognized and disclosed cumulative losses of approximately $2.0 billion on the low-rate initial production (LRIP) phase of
the B-21 program. As of September 30, 2026, the remaining loss accrual totaled $1.0 billion, which is included in Other current liabilities.
Net EAC Adjustments
The following table presents the effect of aggregate net EAC adjustments:
Three Months Ended September
30
Nine Months Ended September
30
$ in millions, except per share data 	2026 	2025 	2026 	2025
Revenue 	$ 	240 $ 	181 $ 	344 $ 	383
Operating income 	221 	81 	235 	107
Net earnings 	175 	64 	186 	85
Diluted earnings per share 	1.23 	0.45 	1.31 	0.59
Based on a 21 percent federal statutory tax rate.
EAC adjustments can have a significant effect on the company’s financial statements. When such adjustments occur, we generally disclose the nature,
underlying conditions and financial impact of the adjustments. In most cases, EAC adjustments have an equal impact on both revenue and operating
income. However, for contracts in a forward loss position, the impact of EAC adjustments on revenue is different than the impact on operating income
because changes in forward losses also impact cost of sales.
2026 – No EAC adjustments on a single performance obligation had a significant impact on the financial statements during the three months ended
September 30, 2026. During the second quarter of 2026, the company recorded a $91 million unfavorable EAC adjustment on the Graphite Epoxy Motor
(GEM) 63XL program at Space Systems and a $68 million unfavorable EAC adjustment on the Stand-in Attack Weapon (SiAW) program at Defense
Systems. During the first quarter of 2026, the company recorded a $71 million unfavorable EAC adjustment on the GEM 63XL program and a
$157 million net unfavorable EAC adjustment on the first four LRIP lots of the B-21 program at Aeronautics Systems, which was offset by a net reduction
in the loss contingency accrual on the remainder of the program.
2025 – During the third quarter of 2025, the company recorded a $68 million favorable EAC adjustment in the restricted advanced microelectronics
portfolio at Mission Systems as well as a $122 million unfavorable EAC adjustment on the first and second LRIP lots of the B-21 program, which was
offset by a net reduction in the loss contingency accrual on the remaining LRIP lots. During the second quarter of 2025, the company recorded a
$76 million favorable EAC adjustment on the engineering and manufacturing development (EMD) phase of the Sentinel program at Defense Systems.
During the first quarter of 2025, the company recorded a $226 million unfavorable EAC adjustment on the first and second LRIP lots of the B-21 program
at Aeronautics Systems.
Backlog
Backlog represents the future sales we expect to recognize on firm orders received by the company and is equivalent to the company’s remaining
performance obligations at the end of each period. It comprises both funded backlog (firm orders for which funding is authorized and appropriated) and
unfunded backlog. Unexercised contract options and indefinite delivery indefinite quantity (IDIQ) contracts are not included in backlog until the time an
option or IDIQ task order is exercised or awarded. Backlog is converted into sales as costs are incurred or deliveries are made.
Company backlog as of September 30, 2026 was $109.6 billion. Of our September 30, 2026 backlog, we expect to recognize approximately 35 percent as
revenue over the next 12 months and 55 percent as revenue over the next 24 months, with the remainder to be recognized thereafter.
Contract Assets and Liabilities
For each of the company’s contracts, the timing of revenue recognition, customer billings, and cash collections results in a net contract asset or liability at
the end of each reporting period. Contract assets are equivalent to and reflected as Unbilled receivables in the unaudited condensed consolidated statements
of financial position and are primarily related to long-term contracts where revenue recognized under the cost-to-cost method exceeds amounts billed to
customers. Contract liabilities are equivalent to and reflected as Advance payments and billings in excess of
(1)
(1)
(1)
-6-

-- 8 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
costs incurred in the unaudited condensed consolidated statements of financial position. The amount of revenue recognized for the three and nine months
ended September 30, 2026 that was included in the December 31, 2025 contract liability balance was $552 million and $3.1 billion, respectively. The
amount of revenue recognized for the three and nine months ended September 30, 2025 that was included in the December 31, 2024 contract liability
balance was $431 million and $3.1 billion, respectively.
Disaggregation of Revenue
See Note 10 for information regarding the company’s sales by customer type, contract type and geographic region for each of our segments. We believe
those categories best depict how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors.
Property, Plant, and Equipment (PP&E)
In connection with the company’s first quarter 2026 agreement with the U.S. Air Force to expand production capacity and increase the aircraft production
rate for the B-21 program, we agreed to sell an aircraft to the U.S. Air Force that we had previously planned to utilize as a company-owned test asset.
While the sale of this asset accelerates the LRIP aircraft delivery schedule, it does not change the number of aircraft we expect to deliver under the LRIP
phase of the program. Because the company previously intended to use the test asset for internal purposes, we recognized the acquisition costs as capital
expenditures and included it in PP&E. As we regularly sell this type of asset to customers in the ordinary course of business, we recorded the sale as a
revenue transaction and included the net book value of the asset in Operating costs and expenses. Although we generally classify proceeds from revenue
transactions as cash inflows from operating activities, we recognized the proceeds from this transaction as cash inflows from investing activities, consistent
with our prior recognition of the cost to acquire the asset as capital expenditures. The company received cash payments of $371 million related to the sale
during the third quarter of 2026 and included it in Proceeds from sale of equipment to a customer in the consolidated statements of cash flows.
During the nine months ended September 30, 2026, the company received lease incentives for landlord funded leasehold improvements of $90 million
related to Aeronautics Systems real estate leases, which were recorded in PP&E and included in non-cash investing activities.
Non-cash investing activities for the nine months ended September 30, 2026 and 2025 include capital expenditures incurred but not yet paid of
$149 million and $140 million, respectively.
Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss, net of tax, are as follows:
$ in millions 	September 30, 2026 	December 31, 2025
Cumulative translation adjustment 	$ 	(131) $ 	(131)
Other, net 	(1) 	5
Total accumulated other comprehensive loss 	$ 	(132) $ 	(126)
Related Party Transactions
For all periods presented, the company had no material related party transactions.
Accounting Standards Updates
On November 4, 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03 Disaggregation of
Income Statement Expenses (Subtopic 220-40). ASU 2024-03 requires disaggregation of certain expense captions into specified categories in disclosures
within the footnotes to the financial statements. ASU 2024-03 will be effective for annual periods beginning January 1, 2027 and interim periods beginning
January 1, 2028. We expect to adopt ASU 2024-03 on a prospective basis; the standard will not have an impact on the company’s consolidated financial
position, results of operations or cash flows.
On September 18, 2025, the FASB issued ASU No. 2025-06 Targeted Improvements to the Accounting for Internal-Use Software (Subtopic 350-40). ASU
2025-06 removes references to prescriptive and sequential software development stages, requiring companies to capitalize internal-use software costs when
management commits to funding the software project and it is probable the project will be completed. ASU 2025-06 will be effective for annual and
interim periods beginning January 1, 2028, and can be applied on a prospective, modified prospective, or retrospective basis. We do not currently expect
the standard will have a material impact on the company’s consolidated financial position, results of operations or cash flows.
On December 8, 2025, the FASB issued ASU No. 2025-11 Interim Reporting (Topic 270): Narrow-Scope Improvements. ASU 2025-11 clarifies the
applicability of Topic 270 and the form and content of interim financial
-7-

-- 9 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
statements. In addition, ASU 2025-11 requires entities to disclose material events occurring since the last annual reporting period. ASU 2025-11 will be
effective for interim periods beginning January 1, 2028, and can be applied on a prospective or retrospective basis. We are evaluating the disclosure impact
of ASU 2025-11; however, the standard will not have an impact on the company’s consolidated financial position, results of operations or cash flows.
Other accounting standards updates adopted and/or issued, but not effective until after September 30, 2026, are not expected to have a material effect on the
company’s consolidated financial position, results of operations and/or cash flows.
2. EARNINGS PER SHARE, SHARE REPURCHASES AND DIVIDENDS ON COMMON STOCK
Basic Earnings Per Share
We calculate basic earnings per share by dividing net earnings by the weighted-average number of shares of common stock outstanding during each period.
Diluted Earnings Per Share
Diluted earnings per share include the dilutive effect of awards granted to employees under stock-based compensation plans. The dilutive effect of these
securities totaled 0.3 million shares for each of the three and nine months ended September 30, 2026. The dilutive effect of these securities totaled 0.4
million shares and 0.3 million shares for the three and nine months ended September 30, 2025, respectively.
Share Repurchases
On December 11, 2024, the company’s board of directors authorized a share repurchase program of up to $3.0 billion in share repurchases of the company’s
common stock. Repurchases under the program commenced in September 2025 and $2.5 billion of the share repurchase authorization remained as of
September 30, 2026. We had no repurchases of common stock during the three months ended September 30, 2026.
Share repurchases take place from time to time, subject to market and regulatory conditions and management’s discretion, in the open market or in
privately negotiated transactions. The company retires its common stock upon repurchase and, in the periods presented, has not made any purchases of
common stock other than in connection with these publicly announced repurchase programs.
Dividends on Common Stock
In May 2026, the company increased the quarterly common stock dividend 7 percent to $2.47 per share from the previous amount of $2.31 per share.
3. INVENTORIED COSTS, NET
Inventoried costs, net consisted of the following:
$ in millions 	September 30, 2026 	December 31, 2025
Raw materials 	$ 	308 $ 	306
Work in process 	979 	945
Finished goods 	74 	58
Inventoried costs, net 	$ 	1,361 $ 	1,309
-8-

-- 10 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
4. INCOME TAXES
In July 2025, the One Big Beautiful Bill Act (OBBBA) was enacted. Key income tax-related provisions of the OBBBA include the repeal of mandatory
capitalization of research and development expenditures under Internal Revenue Code (IRC) Section 174 (reinstating full expensing beginning in 2025),
extension of bonus depreciation, and revisions to international tax regimes. As part of the enactment of the OBBBA, the company became subject to the
corporate alternative minimum tax (CAMT) and recorded CAMT credit carryforwards of $187 million during 2025. In February 2026, the Internal
Revenue Service (IRS) issued Notice 2026-7, providing interim relief for the CAMT through a favorable adjustment related to the amortization of research
and development expenditures under IRC Section 174. The company recognized the impacts of Notice 2026-7 during the first quarter of 2026, resulting in
a $187 million decrease in CAMT credit carryforwards and a corresponding increase in Taxes receivable, as well as a $19 million reduction to federal
income tax expense.
Three Months Ended September 30 Nine Months Ended September 30
$ in millions 	2026 	2025 	2026 	2025
Federal and foreign income tax expense 	$ 	174 	$ 	223 	$ 	403 	$ 	573
Effective income tax rate 	13.4 % 	16.9 % 	11.5 % 	17.2 %
Current Quarter
Third quarter 2026 income tax expense decreased $49 million, or 22 percent, due to a lower effective tax rate (ETR) and $25 million of lower earnings
before income taxes. The third quarter 2026 ETR decreased to 13.4 percent from 16.9 percent principally due to higher research credits. The third quarter
2026 ETR includes benefits of $112 million for research credits and $15 million for foreign-derived deduction-eligible income (FDDEI), partially offset by
$21 million of interest expense on unrecognized tax benefits. The third quarter 2025 ETR included benefits of $66 million for research credits and
$16 million for foreign derived intangible income (FDII), partially offset by $19 million of interest expense on unrecognized tax benefits.
Year to Date
Year to date 2026 income tax expense decreased $170 million, or 30 percent, due to a lower ETR, partially offset by $168 million of higher earnings before
income taxes. The year to date 2026 ETR decreased to 11.5 percent from 17.2 percent primarily due to the remeasurement of unrecognized tax benefits
during the second quarter of 2026 given recent developments with the IRS towards resolving our previously filed federal income tax returns and refund
claims, as well as higher research credits, including a $19 million benefit related to the CAMT guidance discussed above. The year to date 2026 ETR
includes benefits of $356 million for research credits, inclusive of the unrecognized tax benefit remeasurement of $115 million, and $35 million for FDDEI,
partially offset by $46 million of interest expense on unrecognized tax benefits. The year to date 2025 ETR included benefits of $169 million for research
credits and $34 million for FDII, partially offset by $53 million of interest expense on unrecognized tax benefits and $17 million of tax expense related to
nondeductible goodwill in the divested training services business.
We file income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. Certain matters related to the company’s 2018-2024
federal income tax returns are currently under IRS examination. Certain matters related to the company’s 2014-2017 federal income tax returns and refund
claims related to its 2007-2016 federal tax returns are currently under review by the IRS Appeals Office.
Current unrecognized tax benefits, which are included in Other current liabilities, were $800 million and $436 million as of September 30, 2026 and
December 31, 2025, respectively. Non-current unrecognized tax benefits, which are included in Other non-current liabilities, were $1.3 billion and
$1.6 billion as of September 30, 2026 and December 31, 2025, respectively.
Taxes receivable, which are included in Prepaid expenses and other current assets in the unaudited condensed consolidated statements of financial position,
were $1.0 billion as of September 30, 2026 and $924 million as of December 31, 2025.
5. FAIR VALUE OF FINANCIAL INSTRUMENTS
The company holds a portfolio of marketable securities including investments to partially fund non-qualified employee benefit plans as well as investments
in companies that are advancing or developing technologies applicable to our business. A portion of these securities are held in common/collective trust
funds and are measured at fair value using net asset value (NAV) per share as a practical expedient; therefore, they are not categorized in the
-9-

-- 11 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
fair value hierarchy table below. Marketable securities are included in Other non-current assets in the unaudited condensed consolidated statements of
financial position.
The company’s derivative portfolio consists primarily of foreign currency forward contracts. Where model-derived valuations are appropriate, the company
utilizes the income approach to determine the fair value using internal models based on observable market inputs.
The following table presents the financial assets and liabilities the company records at fair value identified by the level of inputs used to determine fair
value:
September 30, 2026 	December 31, 2025
$ in millions 	Level 1 	Level 2 	Level 3 	Total 	Level 1 	Level 2 	Level 3 	Total
Financial Assets
Marketable securities 	$ 	397 $ 	1 $ 	22 $ 	420 $ 	454 $ 	— $ 	24 $ 	478
Marketable securities valued
using NAV 	4 	5
Total marketable securities 	397 	1 	22 	424 	454 	— 	24 	483
Derivatives 	— 	(1) 	— 	(1) 	— 	2 	— 	2
There were no transfers of financial instruments into or out of Level 3 of the fair value hierarchy during the nine months ended September 30, 2026.
During the second quarter of 2026, the company sold its investment in a public company for $107 million and recognized a related gain of $35 million.
Unrealized gains and losses from marketable securities, which are reflected in Other, net on the unaudited condensed consolidated statement of earnings
and comprehensive income, were not material for the three and nine months ended September 30, 2026. Unrealized gains and losses from marketable
securities were $82 million and $92 million for the three and nine months ended September 30, 2025.
The notional value of the company’s foreign currency forward contracts at September 30, 2026 and December 31, 2025 was $291 million and $308 million,
respectively. The portion of notional value designated as a cash flow hedge at September 30, 2026 and December 31, 2025 was $147 million and
$167 million, respectively.
The derivative fair values and related unrealized gains/losses at September 30, 2026 and December 31, 2025 were not material.
The carrying value of cash and cash equivalents approximates fair value.
Long-term Debt
The estimated fair value of the company’s long-term debt was $13.7 billion and $15.1 billion as of September 30, 2026 and December 31, 2025,
respectively. We calculated the fair value of long-term debt using Level 2 inputs, based on interest rates available for debt with terms and maturities similar
to the company’s existing debt arrangements. The current portion of long-term debt is recorded in Other current liabilities in the unaudited condensed
consolidated statements of financial position.
Issuance of Senior Notes
During the nine months ended September 30, 2026, the company issued no unsecured senior notes.
In May 2025, the company issued $1.0 billion of unsecured senior notes for general corporate purposes, including debt repayment, share repurchases, and
working capital, as follows:
• $500 million of 4.65% senior notes due 2030 (the “2030 Notes”) and
• $500 million of 5.25% senior notes due 2035 (the “2035 Notes”).
We refer to the 2030 Notes and 2035 Notes together, as the “notes.” Interest on the notes is payable semi-annually in arrears. The notes are generally
subject to redemption, in whole or in part, at the company’s discretion at any time, or from time to time, prior to maturity at a redemption price equal to the
greater of 100% of the principal amount of the notes to be redeemed or an applicable “make-whole” amount, plus accrued and unpaid interest.
Repayment of Senior Notes
In March 2026, the company repaid $270 million of 7.875% unsecured senior notes and $257 million of 7.75% unsecured senior notes upon maturity.
In January 2025, the company repaid $1.5 billion of 2.93% unsecured senior notes upon maturity.
-10-

-- 12 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
6. INVESTIGATIONS, CLAIMS AND LITIGATION
For over 25 years, the company has worked closely with the United States Navy, the United States Environmental Protection Agency, the New York State
Department of Environmental Conservation, the New York State Department of Health and other federal, state and local governmental authorities, to
address environmental conditions allegedly resulting from historic operations at the former United States Navy and Grumman facilities in Bethpage, New
York. We have incurred, and expect to continue to incur, as included in Note 7, substantial remediation costs related to these Bethpage environmental
conditions, including potential costs relating to unanticipated developments such as new discoveries of potential contaminants. It is also possible that
applicable remediation standards and other requirements to which we are subject may continue to change, and that our costs may increase materially. In
2022, we resolved several disputes and regulatory proceedings concerning the scope and allocation of remediation responsibilities and costs related to this
site and we continue remediation consistent with agreements through which those disputes were resolved. The company continues to be involved in other
remediation-related disputes, none of which are material individually or in the aggregate. We are also a party to various individual lawsuits and a putative
class action in the Eastern District of New York alleging personal injury and property damage related to the legacy Bethpage environmental conditions (the
“Bethpage EDNY cases”). The court had previously stayed the filed individual lawsuits and, at an April 24, 2026 hearing, denied plaintiffs’ motion to lift
that stay as to a subset of plaintiffs. The parties have submitted supplemental briefing on pending class certification and expert motions in the putative class
action. On September 17, 2026, the court granted the parties’ joint request to defer decision on the class certification and expert motions in deference to the
parties’ mediation process. We are also a party, and may become a party, to other lawsuits brought by or against insurance carriers, and by other individual
plaintiffs and/or putative classes, as well as other parties. We cannot at this time predict or reasonably estimate the potential outcomes or ranges of possible
liability of the Bethpage EDNY cases.
The company received from the U.S. Department of Justice (DOJ) a criminal subpoena on December 9, 2022, and a civil investigative demand (CID) on
February 2, 2023, both seeking information regarding financial and cost accounting and controls focused on the interest rate assumptions the company used
to determine our U.S. Government Cost Accounting Standards (CAS) pension expense, which are the subject of the Defense Contract Management Agency
(DCMA) inquiry we discuss in Note 7 below. On May 20, 2026, DOJ confirmed that, based on the information it had learned to date, the Criminal Division
closed its inquiry into this matter. The company continues to engage with the government in relation to the CID and the DCMA inquiry. We cannot at this
point predict the outcome of these remaining matters.
The company is a party to various other investigations, lawsuits, arbitration, claims, enforcement actions and other legal proceedings, including
government investigations and claims, that arise in the ordinary course of our business. The nature of legal proceedings is such that we cannot assure the
outcome of any particular matter. However, based on information available to the company to date, the company does not believe that the outcome of any
of these other matters pending against the company is likely to have a material adverse effect on the company’s unaudited condensed consolidated financial
position as of September 30, 2026, or its annual results of operations and/or cash flows.
7. COMMITMENTS AND CONTINGENCIES
U.S. Government Cost Claims and Contingencies
From time to time, the company is advised of claims by the U.S. government concerning certain potential disallowed costs, plus, at times, penalties and
interest. When such findings are presented, the company and U.S. government representatives engage in discussions to enable the company to evaluate the
merits of these claims, as well as to assess the amounts being claimed. Where appropriate, provisions are made to reflect the company’s estimated exposure
for such potential disallowed costs. Such provisions are reviewed periodically using the most recent information available. The company believes it has
adequately accrued for disputed amounts that are probable and reasonably estimable, and that the outcome of any such matters would not have a material
adverse effect on its unaudited condensed consolidated financial position as of September 30, 2026, or its annual results of operations and/or cash flows.
In 2019, the DCMA raised questions about an interest rate assumption used by the company to determine our CAS pension expense. On June 1, 2020,
DCMA provided written notice that the assumptions the company used during the period 2013-2019 were potentially noncompliant with CAS. We
submitted a formal response on July 31, 2020, which we believed demonstrates the appropriateness of the assumptions used. On November 24, 2020,
DCMA replied to the company’s response, disagreeing with our position and requesting additional input, which we provided on February 22, 2021. We
subsequently continued to exchange correspondence and engage with DCMA on this
-11-

-- 13 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
matter, including responding to requests for and providing additional information. On February 15, 2024, DCMA sent to the company a Contracting
Officer’s determination of noncompliance with CAS, which is an interim, non-final determination, and the parties engaged in discussions. In addition, as
noted in Note 6 above, the company received from the DOJ a criminal subpoena on December 9, 2022 and a CID on February 2, 2023, both seeking
information related to the interest rate assumptions at issue in our discussions with DCMA. On May 20, 2026, DOJ confirmed that, based on the
information it had learned to date, the Criminal Division closed its inquiry into this matter. The company continues to engage with the government in
relation to the CID and the DCMA inquiry. We cannot at this point predict the outcome of these remaining matters. The sensitivity to changes in interest
rate assumptions makes it reasonably possible the outcome of these matters could have a material adverse effect on our financial position, results of
operations and/or cash flows, although we are not currently able to estimate a range of any potential loss.
Environmental Matters
The table below summarizes the amount of accrued and deferred costs associated with the company’s environmental remediation liabilities as of September
30, 2026 and December 31, 2025:
$ in millions 	September 30, 2026 	December 31, 2025
Accrued costs 	$ 	554 $ 	547
Deferred costs 	511 	502
As of September 30, 2026, $215 million is recorded in Other current liabilities and $339 million is recorded in Other non-current liabilities in the unaudited condensed
consolidated statements of financial position. Estimated remediation costs are not discounted to present value.
The company defers the portion of environmental remediation costs we expect to be recoverable through overhead charges on U.S. government contracts. As of
September 30, 2026, $200 million is deferred in Prepaid expenses and other current assets and $311 million is deferred in Other non-current assets in the unaudited
condensed consolidated statements of financial position. These amounts are routinely evaluated for recoverability.
Reasonably possible future costs in excess of accrued costs were $403 million and $380 million as of September 30, 2026 and December 31, 2025,
respectively. We currently expect any such future costs would be recoverable through overhead charges on our U.S. government contracts in a similar
proportion as the amounts deferred in the table above.
Although we cannot predict whether (i) new information gained as our environmental remediation projects progress, (ii) changes in remediation standards
or other requirements to which we are subject, or (iii) other changes in facts and circumstances will materially affect the estimated liability accrued, we do
not anticipate that future remediation expenditures associated with our currently identified projects will have a material adverse effect on the company’s
unaudited condensed consolidated financial position as of September 30, 2026, or its annual results of operations and/or cash flows.
Financial Arrangements
In the ordinary course of business, the company uses standby letters of credit and guarantees issued by commercial banks and surety bonds issued
principally by insurance companies to guarantee the performance on certain obligations. At September 30, 2026, there were $615 million of stand-by letters
of credit and guarantees and $271 million of surety bonds outstanding.
Commercial Paper
The company maintains a commercial paper program that serves as a source of short-term financing with capacity to issue unsecured commercial paper
notes up to $3.0 billion. At September 30, 2026, there were no commercial paper borrowings outstanding.
Credit Facilities
The company maintains a five-year senior unsecured revolving credit facility in an aggregate principal amount of $3.0 billion (the “2025 Credit
Agreement”) that matures in September 2030 and is intended to support the company's commercial paper program and other general corporate purposes.
Commercial paper borrowings reduce the amount available for borrowing under the 2025 Credit Agreement. At September 30, 2026, there were no
borrowings outstanding under this facility.
The 2025 Credit Agreement contains generally customary terms and conditions, including covenants restricting the company’s ability to sell all or
substantially all of its assets, merge or consolidate with another entity or undertake
(1)
(2)
(1)
(2)
-12-

-- 14 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
other fundamental changes and incur liens. The company also cannot permit the ratio of its debt to capitalization (as set forth in the credit agreement) to
exceed 65 percent.
At September 30, 2026, the company was in compliance with all covenants under its credit agreements.
8. RETIREMENT BENEFITS
The cost to the company of its pension and other postretirement benefit (OPB) plans is shown in the following table:
Three Months Ended September 30 	Nine Months Ended September 30
Pension
Benefits 	OPB
Pension
Benefits 	OPB
$ in millions 	2026 	2025 	2026 	2025 	2026 	2025 	2026 	2025
Components of net periodic benefit cost
(benefit)
Service cost 	$ 	53 $ 	55 $ 	1 $ 	1 $ 	159 $ 	163 $ 	3 $ 	3
Interest cost 	398 	404 	15 	16 	1,196 	1,209 	44 	47
Expected return on plan assets 	(565) 	(540) 	(22) 	(22) 	(1,695) 	(1,619) 	(66) 	(64)
Amortization of prior service credit 	— 	— 	(1) 	(1) 	— 	— 	(2) 	(2)
Other 	— 	— 	— 	— 	— 	7 	— 	—
Net periodic benefit cost (benefit) 	$ 	(114) $ 	(81) $ 	(7) $ 	(6) $ 	(340) $ 	(240) $ 	(21) $ 	(16)
Employer Contributions
The company sponsors defined benefit pension and OPB plans, as well as defined contribution plans. We fund our defined benefit pension plans annually
in a manner consistent with the Employee Retirement Income Security Act of 1974, as amended by the Pension Protection Act of 2006.
Contributions made by the company to its retirement plans are as follows:
Three Months Ended
September 30
Nine Months Ended September
30
$ in millions 	2026 	2025 	2026 	2025
Defined benefit pension plans 	$ 	24 $ 	25 $ 	66 $ 	67
OPB plans 	5 	7 	26 	27
Defined contribution plans 	145 	133 	532 	517
9. STOCK COMPENSATION PLANS AND OTHER COMPENSATION ARRANGEMENTS
Stock Awards
The following table presents the number of restricted stock rights (RSRs), restricted performance stock rights (RPSRs), and market stock units (MSUs)
granted to employees under the company’s long-term incentive stock plan and the grant date aggregate fair value of those stock awards for the periods
presented:
Nine Months Ended September
30
in millions 	2026 	2025
RSRs granted 	0.1 	0.1
RPSRs/MSUs granted 	0.1 	0.1
Grant date aggregate fair value 	$ 	168 $ 	104
RSRs typically vest on the third anniversary of the grant date, while RPSRs and MSUs generally vest and pay out based on the achievement of certain
performance metrics and/or market conditions over a three-year period for RPSRs and through December 31, 2031 for MSUs.
-13-

-- 15 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Cash Awards
The following table presents the minimum and maximum aggregate payout amounts related to cash units (CUs) and cash performance units (CPUs) granted
to employees in the periods presented:
Nine Months Ended September
30
$ in millions 	2026 	2025
Minimum aggregate payout amount 	$ 	— $ 	35
Maximum aggregate payout amount 	163 	199
CUs typically vest and settle in cash on the third anniversary of the grant date, while CPUs generally vest and pay out in cash based on the achievement of
certain performance metrics over a three-year period. During the nine months ended September 30, 2026, there were no CUs granted to employees.
10. SEGMENT INFORMATION
The company is aligned in four operating sectors, which also comprise our reportable segments: Aeronautics Systems, Defense Systems, Mission Systems
and Space Systems. We generally organize our segments based on the nature of products and services offered.
-14-

-- 16 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
The following table presents sales, operating costs and expenses, and operating income by segment:
Three Months Ended September
30 Nine Months Ended September
30
$ in millions 	2026 	2025 	2026 	2025
Aeronautics Systems
Sales 	$ 	3,575 $ 	3,142 $ 	10,377 $ 	9,070
Operating costs and expenses:
Product 	2,463 	2,108 	7,180 	6,575
Service 	698 	690 	2,048 	1,940
Intersegment 	37 	39 	105 	112
Aeronautics Systems operating income 	377 	305 	1,044 	443
Defense Systems
Sales 	2,307 	2,059 	6,299 	5,855
Operating costs and expenses:
Product 	1,717 	1,483 	4,668 	4,117
Service 	287 	297 	893 	940
Intersegment 	53 	45 	148 	132
Defense Systems operating income 	250 	234 	590 	666
Mission Systems
Sales 	3,155 	3,093 	9,266 	9,057
Operating costs and expenses:
Product 	1,895 	1,825 	5,477 	5,500
Service 	440 	466 	1,312 	1,383
Intersegment 	320 	287 	1,043 	857
Mission Systems operating income 	500 	515 	1,434 	1,317
Space Systems
Sales 	2,749 	2,698 	7,982 	7,912
Operating costs and expenses:
Product 	1,956 	1,980 	5,817 	5,702
Service 	321 	297 	909 	1,021
Intersegment 	160 	123 	473 	328
Space Systems operating income 	312 	298 	783 	861
Intersegment profit eliminations 	(94) 	(75) 	(276) 	(223)
Total segment operating income 	1,345 	1,277 	3,575 	3,064
FAS/CAS operating adjustment 	15 	67 	29 	193
Unallocated corporate expense 	(91) 	(102) 	(250) 	(17)
Total operating income 	1,269 	1,242 	3,354 	3,240
Other (expense) income
Interest expense 	(158) 	(161) 	(481) 	(490)
Non-operating FAS pension benefit 	167 	136 	499 	403
Other, net 	20 	106 	124 	175
Earnings before income taxes 	$ 	1,298 $ 	1,323 $ 	3,496 $ 	3,328
-15-

-- 17 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
FAS/CAS Operating Adjustment
For financial statement purposes, we account for our employee pension plans in accordance with FAS. However, the cost of these plans is charged to our
contracts in accordance with applicable Federal Acquisition Regulation (FAR) and CAS requirements. The FAS/CAS operating adjustment reflects the
difference between CAS pension expense included as cost in segment operating income and the service cost component of FAS expense included in total
operating income.
Unallocated Corporate Expense
Unallocated corporate expense includes the portion of corporate costs not considered allowable or allocable under applicable FAR and CAS requirements,
and therefore not allocated to the segments, such as changes in deferred state income taxes and a portion of management and administration, legal,
environmental, compensation, retiree benefits, advertising and other corporate unallowable costs. Unallocated corporate expense also includes costs not
considered part of management’s evaluation of segment operating performance, such as amortization of purchased intangible assets and the additional
depreciation expense related to the step-up in fair value of property, plant and equipment acquired through business combinations, as well as certain
compensation and other costs.
-16-

-- 18 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Disaggregation of Revenue
Sales by Customer Type 	Three Months Ended September 30 	Nine Months Ended September 30
2026 	2025 	2026 	2025
$ in millions 	$ 	% 	$ 	% 	$ 	% 	$ 	%
Aeronautics Systems
U.S. government 	$ 	2,846 	80 % $ 	2,530 	82 % $ 	8,349 	81 % $ 	7,346 	82 %
International 	665 	19 % 	564 	18 % 	1,857 	18 % 	1,586 	18 %
Other customers 	23 	1 % 	6 	— % 	55 	1 % 	17 	— %
Intersegment sales 	41 	42 	116 	121
Aeronautics Systems sales 	3,575 	3,142 	10,377 	9,070
Defense Systems
U.S. government 	1,934 	86 % 	1,570 	78 % 	5,263 	86 % 	4,632 	81 %
International 	294 	13 % 	419 	21 % 	808 	13 % 	1,013 	18 %
Other customers 	20 	1 % 	19 	1 % 	62 	1 % 	61 	1 %
Intersegment sales 	59 	51 	166 	149
Defense Systems sales 	2,307 	2,059 	6,299 	5,855
Mission Systems
U.S. government 	2,244 	81 % 	2,166 	79 % 	6,403 	80 % 	6,421 	80 %
International 	487 	18 % 	557 	20 % 	1,514 	19 % 	1,537 	19 %
Other customers 	38 	1 % 	31 	1 % 	114 	1 % 	84 	1 %
Intersegment sales 	386 	339 	1,235 	1,015
Mission Systems sales 	3,155 	3,093 	9,266 	9,057
Space Systems
U.S. government 	2,411 	94 % 	2,366 	93 % 	7,111 	95 % 	7,024 	93 %
International 	37 	1 % 	63 	2 % 	128 	2 % 	154 	2 %
Other customers 	123 	5 % 	132 	5 % 	215 	3 % 	367 	5 %
Intersegment sales 	178 	137 	528 	367
Space Systems sales 	2,749 	2,698 	7,982 	7,912
Total
U.S. government 	9,435 	85 % 	8,632 	83 % 	27,126 	85 % 	25,423 	84 %
International 	1,483 	13 % 	1,603 	15 % 	4,307 	14 % 	4,290 	14 %
Other customers 	204 	2 % 	188 	2 % 	446 	1 % 	529 	2 %
Total Sales 	$ 11,122 	$ 10,423 	$ 31,879 	$ 30,242
Sales to the U.S. government include sales from contracts for which we are the prime contractor, as well as those for which we are a subcontractor and the ultimate
customer is the U.S. government. Each of the company’s segments derives a substantial percentage of its revenue from the U.S. government.
International sales include sales from contracts for which we are the prime contractor, as well as those for which we are a subcontractor and the ultimate customer is an
international customer to the extent that information is available to us or can be reasonably estimated. These sales include foreign military sales contracted through the
U.S. government.
Percentages calculated based on external customer sales.
(3) 	(3) 	(3) 	(3)
(1)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(3)
-17-

-- 19 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Sales by Contract Type 	Three Months Ended September 30 	Nine Months Ended September 30
2026 	2025 	2026 	2025
$ in millions 	$ 	% 	$ 	% 	$ 	% 	$ 	%
Aeronautics Systems
Cost-type 	$ 	1,607 	45 % $ 	1,454 	47 % $ 	4,573 	45 % $ 	4,254 	48 %
Fixed-price 	1,927 	55 % 	1,646 	53 % 	5,688 	55 % 	4,695 	52 %
Intersegment sales 	41 	42 	116 	121
Aeronautics Systems sales 	3,575 	3,142 	10,377 	9,070
Defense Systems
Cost-type 	1,234 	55 % 	1,028 	51 % 	3,461 	56 % 	3,077 	54 %
Fixed-price 	1,014 	45 % 	980 	49 % 	2,672 	44 % 	2,629 	46 %
Intersegment sales 	59 	51 	166 	149
Defense Systems sales 	2,307 	2,059 	6,299 	5,855
Mission Systems
Cost-type 	1,131 	41 % 	1,219 	44 % 	3,387 	42 % 	3,788 	47 %
Fixed-price 	1,638 	59 % 	1,535 	56 % 	4,644 	58 % 	4,254 	53 %
Intersegment sales 	386 	339 	1,235 	1,015
Mission Systems sales 	3,155 	3,093 	9,266 	9,057
Space Systems
Cost-type 	1,293 	50 % 	1,351 	53 % 	4,017 	54 % 	4,453 	59 %
Fixed-price 	1,278 	50 % 	1,210 	47 % 	3,437 	46 % 	3,092 	41 %
Intersegment sales 	178 	137 	528 	367
Space Systems sales 	2,749 	2,698 	7,982 	7,912
Total
Cost-type 	5,265 	47 % 	5,052 	48 % 	15,438 	48 % 	15,572 	51 %
Fixed-price 	5,857 	53 % 	5,371 	52 % 	16,441 	52 % 	14,670 	49 %
Total Sales 	$ 11,122 	$ 10,423 	$ 31,879 	$ 30,242
Percentages calculated based on external customer sales.
(1) 	(1) 	(1) 	(1)
(1)
-18-

-- 20 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Sales by Geographic Region 	Three Months Ended September 30 	Nine Months Ended September 30
2026 	2025 	2026 	2025
$ in millions 	$ 	% 	$ 	% 	$ 	% 	$ 	%
Aeronautics Systems
United States 	$ 	2,869 	81 % $ 	2,536 	82 % $ 	8,404 	82 % $ 	7,363 	82 %
Asia/Pacific 	251 	7 % 	221 	7 % 	743 	7 % 	647 	7 %
Europe 	393 	11 % 	321 	10 % 	1,051 	10 % 	891 	10 %
Other geographic regions 	21 	1 % 	22 	1 % 	63 	1 % 	48 	1 %
Intersegment sales 	41 	42 	116 	121
Aeronautics Systems sales 	3,575 	3,142 	10,377 	9,070
Defense Systems
United States 	1,954 	87 % 	1,589 	79 % 	5,325 	87 % 	4,693 	82 %
Asia/Pacific 	106 	5 % 	111 	6 % 	297 	5 % 	271 	5 %
Europe 	132 	6 % 	251 	12 % 	386 	6 % 	589 	10 %
Other geographic regions 	56 	2 % 	57 	3 % 	125 	2 % 	153 	3 %
Intersegment sales 	59 	51 	166 	149
Defense Systems sales 	2,307 	2,059 	6,299 	5,855
Mission Systems
United States 	2,282 	82 % 	2,197 	80 % 	6,517 	81 % 	6,505 	81 %
Asia/Pacific 	112 	4 % 	147 	5 % 	374 	5 % 	407 	5 %
Europe 	266 	10 % 	318 	12 % 	820 	10 % 	820 	10 %
Other geographic regions 	109 	4 % 	92 	3 % 	320 	4 % 	310 	4 %
Intersegment sales 	386 	339 	1,235 	1,015
Mission Systems sales 	3,155 	3,093 	9,266 	9,057
Space Systems
United States 	2,534 	99 % 	2,498 	98 % 	7,326 	98 % 	7,391 	98 %
Asia/Pacific 	14 	— % 	25 	1 % 	47 	1 % 	48 	1 %
Europe 	19 	1 % 	28 	1 % 	67 	1 % 	74 	1 %
Other geographic regions 	4 	— % 	10 	— % 	14 	— % 	32 	— %
Intersegment sales 	178 	137 	528 	367
Space Systems sales 	2,749 	2,698 	7,982 	7,912
Total
United States 	9,639 	87 % 	8,820 	85 % 	27,572 	86 % 	25,952 	86 %
Asia/Pacific 	483 	4 % 	504 	5 % 	1,461 	5 % 	1,373 	4 %
Europe 	810 	7 % 	918 	8 % 	2,324 	7 % 	2,374 	8 %
Other geographic regions 	190 	2 % 	181 	2 % 	522 	2 % 	543 	2 %
Total Sales 	$ 	11,122 	$ 10,423 	$ 31,879 	$ 30,242
Sales are attributed to countries based on the ultimate customer’s location to the extent that information is available to us or can be reasonably estimated. No country other
than the United States represents greater than 10 percent of total company sales.
Other geographic regions are principally comprised of the Middle East.
Percentages calculated based on external customer sales.
(1)
(3) 	(3) 	(3) 	(3)
(2)
(1)
(2)
(3)
-19-

-- 21 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Capital Expenditures and Depreciation and Amortization
The following table presents capital expenditures and depreciation and amortization for each of our reportable segments and for Corporate:
Three Months Ended September 30 	Nine Months Ended September 30
$ in millions 	2026 	2025 	2026 	2025
Capital Expenditures
Aeronautics Systems 	$ 	106 $ 	102 $ 	175 $ 	250
Defense Systems 	33 	21 	77 	44
Mission Systems 	46 	66 	133 	152
Space Systems 	84 	70 	211 	251
Corporate 	37 	42 	179 	91
Total capital expenditures 	$ 	306 $ 	301 $ 	775 $ 	788
Depreciation and Amortization
Aeronautics Systems 	$ 	97 $ 	92 $ 	274 $ 	273
Defense Systems 	44 	47 	132 	132
Mission Systems 	73 	71 	212 	206
Space Systems 	98 	98 	293 	261
Corporate 	67 	71 	207 	194
Total depreciation and amortization 	$ 	379 $ 	379 $ 	1,118 $ 	1,066
Corporate amounts include the amortization of purchased intangible assets and the additional depreciation expense related to the step-up in fair value of PP&E acquired
through business combinations as they are not considered part of management’s evaluation of segment operating performance.
Assets
Our chief operating decision maker (“CODM”) does not use assets by segment to evaluate segment performance or allocate resources. Therefore, we do not
disclose assets by segment.
(1)
(1)
(1)
-20-

-- 22 of 55 --

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
Northrop Grumman Corporation
Falls Church, Virginia
Results of Review of Interim Financial Information
We have reviewed the accompanying condensed consolidated statement of financial position of Northrop Grumman Corporation and subsidiaries (the
“Company”) as of September 30, 2026, and the related condensed consolidated statements of earnings and comprehensive income and changes in
shareholders’ equity for the three-month and nine-month periods ended September 30, 2026 and 2025, and of cash flows for the nine-month periods ended
September 30, 2026 and 2025 and the related notes (collectively referred to as the “interim financial information”). Based on our reviews, we are not aware
of any material modifications that should be made to the accompanying interim financial information for it to be in conformity with accounting principles
generally accepted in the United States of America.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the
consolidated statement of financial position of Northrop Grumman Corporation and subsidiaries as of December 31, 2025, and the related consolidated
statements of earnings and comprehensive income, changes in shareholders’ equity, and cash flows for the year then ended (not presented herein); and in
our report dated January 26, 2026, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth
in the accompanying condensed consolidated statement of financial position as of December 31, 2025, is fairly stated, in all material respects, in relation to
the audited consolidated statement of financial position from which it has been derived.
Basis for Review Results
This interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying
analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit
conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken
as a whole. Accordingly, we do not express such an opinion.
/s/ 	Deloitte & Touche LLP
McLean, Virginia
October 19, 2026
-21-

-- 23 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
OVERVIEW
Northrop Grumman Corporation (herein referred to as “Northrop Grumman,” the “company,” “we,” “us,” or “our”) is a leading global aerospace and
defense technology company. We deliver a broad range of products, services and solutions to U.S. and international customers, and principally to the U.S.
Department of War (“DoW”) and intelligence community. Our broad portfolio is aligned to support national security priorities and our solutions equip our
customers with capabilities they need to connect, protect and advance humanity.
The company is a leading provider of space systems, military aircraft, missile defense, advanced weapons and long-range fires capabilities, mission
systems, networking and communications, strategic deterrence systems, and breakthrough technologies, such as advanced computing, microelectronics and
cyber. We are focused on competing and winning programs that enable continued growth, performing on our commitments and affordably delivering
capability our customers need. With the investments we've made in advanced technologies, combined with our talented workforce and digital
transformation capabilities, Northrop Grumman is well positioned to meet our customers' needs today and in the future.
The following discussion should be read along with the financial statements included in this Form 10-Q, as well as “Management’s Discussion and
Analysis of Financial Condition and Results of Operations,” “Liquidity and Capital Resources,” “Quantitative and Qualitative Disclosures About Market
Risks” and “Risk Factors” in our 2025 Annual Report on Form 10-K, which provides additional information on our business, the environment in which we
operate and our operating results.
Divestiture of Training Services Business
On May 24, 2025 (the “Divestiture date”), the company completed its previously announced sale of substantially all of the Immersive Mission Solutions
(IMS) operating unit of Defense Systems (the “training services” business or “divestiture”) for $333 million in cash and recorded a pre-tax gain on sale of
$231 million. IMS is a provider of mission training and satellite ground network communications software for U.S. government customers. 2025 operating
results include sales and operating income for the training services business prior to the Divestiture date.
Global Security Environment
The U.S. and its allies continue to face a dynamic global security environment of heightened tensions and instability, threats from state and non-state actors,
including in particular major global powers, as well as terrorist organizations, increasing nuclear tensions, diverse regional security concerns, political
instability and uncertainty concerning global strategic alliances. The market for defense products, services and solutions globally is driven by these
complex and rapidly evolving security challenges, considered in the broader context of political and socioeconomic circumstances and priorities. Our
operations and financial performance, as well as demand for our products and services, are impacted by these events, including global unrest. The same is
true for our suppliers and other business partners.
The ongoing conflicts in Ukraine and Iran and threats elsewhere, particularly in the Middle East and the Western Pacific region, have increased global
tensions and instability and highlighted security requirements globally. These conflicts have resulted in and may continue to result in increased demand for
defense products and services from allies and partner nations, particularly in those regions. We continue to monitor developments in these regions, but have
not experienced, and do not anticipate experiencing, significant adverse financial impacts directly from these conflicts.
We believe the current global security environment, characterized by significant national security threats to the U.S. and its allies, continues to highlight the
need for strong deterrence and robust defense capabilities. We are actively evaluating both opportunities and risks associated with this environment and are
moving with speed and at scale to deliver innovative solutions to our customers. We believe our capabilities, particularly in space, C4ISR, air and missile
defense, battle management, solid rocket motors, advanced weapons, strategic deterrence, survivable aircraft, autonomous aircraft systems and mission
systems should help our customers in the U.S. and globally defend against current and future threats and, as a result, continue to position us for long-term
profitable business growth.
Global Economic Environment
Over the past several years, the global economic environment has experienced challenges, including inflationary pressures; widespread delays and
disruptions in supply chains; constraints on the availability of critical materials, including rare earth minerals and metals; business slowdowns or
shutdowns; workforce challenges and labor shortfalls; and market volatility. These macroeconomic factors have contributed, and could continue to
contribute, to increased costs, delays, disruptions and other performance challenges, as well as increased competing demands for
-22-

-- 24 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
limited resources to address such increased costs and other challenges, for our company, suppliers and partners, and customers.
In addition, increases or fluctuations in interest rates could impact government spending priorities (in the U.S. and allied countries, in particular), including
the demand for defense products. Economic tensions and changes in international trade policies, including, for example, widespread tariffs announced since
last year by the U.S. on its major trading partners, higher tariffs on imported goods and materials and actions taken in response (such as retaliatory tariffs or
other trade protectionist measures or the renegotiation of free trade agreements), could also further impact the global market for defense products, services
and solutions. In addition, following the first quarter 2026 U.S. Supreme Court decision that invalidated tariffs imposed pursuant to the International
Emergency Economic Powers Act (“IEEPA”), the U.S. has announced various tariffs under different statutory authorities. The full impact of these
governmental actions on macroeconomic conditions and on our business is uncertain, difficult to predict and depends on a number of factors, including the
extent and duration of tariffs, the availability of exemptions, changes in the amount and scope of tariffs, any reversal or temporary suspension of announced
tariffs, the availability of refunds for tariffs paid under IEEPA, the imposition of new tariffs and other measures that target countries may take in response to
U.S. trade policies, and possible resulting general inflationary pressures in the global economy. We are continuing to monitor the impact on our business,
suppliers and customers, but do not believe that the tariffs, including the IEEPA tariffs, have had or will have a material adverse effect on our business.
U.S. Political, Budget and Regulatory Environment
The U.S. continues to face an uncertain and evolving political, budget and regulatory environment. In particular, it is difficult to predict the specific course
of future defense budgets. Current and future requirements related to the conflicts in Ukraine and Iran and threats in the Middle East, the Western Pacific
and Latin America and other security priorities, as well as the macroeconomic environment, the national debt, and other domestic priorities, among other
things, in the U.S. and globally, will continue to impact our customers’ budgets, spending and priorities, and our industry. The U.S. political environment
may also impact defense budgets and priorities, issues related to the national debt, and government spending more broadly. We anticipate that issues related
to budgetary priorities, defense spending levels and the debt ceiling will continue to be subjects of considerable debate, with a potentially significant impact
on our programs and the company.
On July 4, 2025, the FY 2025 reconciliation bill titled the One Big Beautiful Bill Act (the “OBBBA”) was enacted. The OBBBA allocated approximately
$150 billion in mandatory defense funding, including funding for air and missile defense, munitions, strategic deterrence, shipbuilding and supply chains
and other military capabilities. The appropriated funds will remain available to be obligated until September 30, 2029 and expended through FY 2034.
Funding from the OBBBA has allowed for increased investments by the DoW in defense modernization projects, homeland missile defense capabilities,
and increased production capacity across a number of key programs. See Note 4 to the financial statements for additional information on key income tax
provisions of the OBBBA.
On February 3, 2026, annual appropriations to fund a vast majority of the federal government for FY 2026, including approximately $859 billion for
defense, were enacted. Appropriations to partially fund the Department of Homeland Security were enacted on April 30, 2026, with the remaining
appropriations enacted on June 10, 2026. On April 3, 2026, the Trump Administration (the “Administration”) released its FY 2027 budget request. The
request includes $1.45 trillion for defense, with $1.1 trillion in the base budget (discretionary funding) and $350 billion in reconciliation (mandatory)
funding. The total defense budget request reflects an increase of 44% ($441 billion) above the FY 2026 enacted levels (including $153 billion in FY 2026
reconciliation funding). Congress is evaluating the Administration’s budget request as it drafts authorization and appropriations legislation for FY 2027.
Additionally, the Administration requested $88 billion in supplemental funding for FY 2026, which included $67 billion to address the operational costs
associated with the Iran conflict and other defense priorities. There is uncertainty as to when Congress will act on the reconciliation funding and
supplemental request.
On September 2, 2026, a continuing resolution (“CR”) was enacted to provide funding for the federal government, including the DoW, through December
11, 2026, generally at FY 2026 funding levels. The CR also requires that any new multi-year contracts for military equipment receive prior Congressional
approval. Annual appropriations for FY 2027 have not yet been enacted, and it remains uncertain when the government will approve full-year FY 2027
appropriations and what levels of funding those appropriations will provide. Government operations under an extended CR could have adverse impacts on
our programs and new starts, in particular. If the CR is not extended or full-year appropriations legislation is not enacted before the current CR expires, a
government shutdown could occur. A prolonged government shutdown could result in program disruptions and limit the U.S. Government’s ability to
progress programs and make timely payments.
-23-

-- 25 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
The Administration has issued numerous executive orders, including orders to undertake a comprehensive overhaul of the Federal Acquisition Regulation,
to reform the DoW defense acquisition process and, more recently, to promote the use of fixed price contracts where appropriate and to address
underperformance and insufficient prioritization of government contracts, insufficient investment in production and production speed and incentive
compensation metrics applicable to defense contractors. See “Risk factors” for further discussion regarding risks associated with executive orders and
regulatory changes. Some of the Administration’s executive orders are subject to ongoing court challenges. In addition, the DoW has outlined initiatives to,
among other efforts, reform government contract accounting and promote supplier cost and pricing transparency. Implementation of certain of these
executive orders and initiatives could adversely affect our business or create a more challenging or costly regulatory, operating and economic environment.
In light of the ongoing conflicts and heightened global instability as well as political tensions and related legal challenges, we expect continued uncertainty
in the global security, U.S. political, budget and regulatory environment. Initiatives to reduce governmental spending, federal budget and debt ceiling
action, and further changes in U.S. government policy positions, including trade and foreign policy, tax policy and DoW policies or priorities, could
materially impact defense spending broadly and the company’s programs in particular.
B-21 Program
In 2015, the U.S. Air Force awarded Northrop Grumman the B-21 contract, which includes a base contract for EMD and five low-rate initial production
(LRIP) options for a baseline total of 21 aircraft. The EMD phase of the program is largely cost type and began at contract award. The LRIP options are
largely fixed price and are expected to continue to be awarded and executed through approximately the end of the decade. We have previously recognized
and disclosed cumulative losses of approximately $2.0 billion on the LRIP phase of the program. Northrop Grumman and the U.S. Air Force have also
established not to exceed (NTE) pricing for two additional lots. Final terms, quantity, and pricing for the NTE lots are not fully negotiated; however, the
average value for these NTE lots is above the average unit price of the five LRIP lots, and the NTE lots include an economic price adjustment clause to
help protect against certain inflationary pressures.
During the first quarter of 2026, we reached an agreement with the U.S. Air Force to expand production capacity for the B-21 program and increase the
aircraft production rate. We continue to expect to invest approximately $2.5 billion over a multi-year period to expand production capacity; in return, we
have the opportunity to earn improved returns on the LRIP and NTE phases of the program.
During the third quarter of 2026, we again reviewed our estimated profitability on the LRIP phase of the program and made no significant changes to the
previously recognized loss. The company’s third quarter 2026 results reflect our current best estimate of cost to complete the LRIP and NTE aircraft, as
well as the outcome of ongoing discussions with our suppliers. If our estimated cost to complete the aircraft changes, or if our assumptions regarding
contract performance, quantities, or supplier negotiations are resolved more or less favorably than what we have estimated, our financial position, results of
operations and/or cash flows could be materially affected.
Sentinel Program
In 2020, the U.S. Air Force awarded Northrop Grumman a $13.3 billion contract for the EMD phase of the Sentinel program. In January 2024, the U.S. Air
Force provided congressional notification that the Sentinel program was under a Nunn-McCurdy breach review, which is required when total program cost
estimates exceed certain defined thresholds. This notification, which had been driven primarily by increases in cost estimates for the Production and
Deployment phases, commenced the process to achieve certification for continuance of the program and update its baseline cost estimates. We are currently
executing under a cost-type contract for the EMD phase, and the Production and Deployment phases are yet to be priced and negotiated.
In July 2024, the Sentinel program was certified for continuation by the DoW upon completion of the Nunn-McCurdy breach review. In connection with
the certification, the DoW directed that the program be restructured, including plans for infrastructure related to the command and launch segment, which
was the main driver of the increased cost estimates for the Production and Deployment phases.
During the second quarter of 2025, we partnered with the U.S. Air Force in defining the preliminary execution framework necessary for successful
restructure of the program. The program restructure will include a revision to the acquisition strategy, joint establishment of a new program baseline, and
other critical preparation activities necessary to re-accomplish Milestone B approval.
During the second and third quarters of 2026, we continued to make progress on joint activities with the U.S. Air Force. These efforts, which included
requirements and design maturation, risk reduction activities, and evaluation of
-24-

-- 26 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
options to accelerate fielding of initial capability, have resulted in further definition and authorization of elements of the program execution plan, resulting
in a $9.4 billion increase in program backlog.
During the third quarter of 2026, we again reviewed our estimated profitability on the Sentinel program and made no significant changes. If our estimated
cost to complete the restructured EMD effort or our achievement of future contract incentives is more or less favorable than what we have estimated, our
financial position, results of operations and/or cash flows could be materially affected.
Operating Performance Assessment and Reporting
In evaluating our operating performance, we primarily focus on changes in sales and operating margin rates. Where applicable, significant fluctuations in
operating performance attributable to individual contracts or programs, or changes in a specific cost element across multiple contracts, are described in our
analysis. Based on this approach and the nature of our operations, the discussion of results of operations below first focuses on our four segments before
distinguishing between products and services. Changes in sales are generally described in terms of volume, while changes in operating margin rates are
generally described in terms of performance and/or contract mix. For purposes of this discussion, volume generally refers to increases or decreases in sales
or cost from production/service activity levels and performance generally refers to non-volume-related changes in profitability, which are typically
described in terms of changes in net EAC adjustments. Contract mix generally refers to changes in the ratio of contract type and/or life cycle (e.g., cost-
type, fixed-price, development, production, and/or sustainment). Contract mix can also refer to differences in the profitability of the programs that drive
changes in sales (e.g., sales growth or decreases on programs with accretive or dilutive margin rates).
CONSOLIDATED OPERATING RESULTS
Selected financial highlights are presented in the table below:
Three Months Ended September
30 	%
Nine Months Ended September
30 	%
$ in millions, except per share amounts 	2026 	2025 	Change 	2026 	2025 	Change
Sales 	$ 	11,122 	$ 	10,423 	7 % $ 	31,879 	$ 	30,242 	5 %
Operating costs and expenses 	9,853 	9,181 	7 % 	28,525 	27,233 	5 %
Gain on sale of business 	— 	— 	NM 	— 	231 	NM
Operating income 	1,269 	1,242 	2 % 	3,354 	3,240 	4 %
Operating margin rate 	11.4% 	11.9% 	10.5% 	10.7%
Federal and foreign income tax expense 	174 	223 	(22)% 	403 	573 	(30)%
Effective income tax rate 	13.4% 	16.9% 	11.5% 	17.2%
Net earnings 	1,124 	1,100 	2 % 	3,093 	2,755 	12 %
Diluted earnings per share 	$ 	7.89 	$ 	7.67 	3 % $ 	21.72 	$ 	19.12 	14 %
Sales
Current Quarter
Third quarter 2026 sales increased $699 million, or 7 percent, driven by higher sales at all four sectors, including a 14 percent increase at Aeronautics
Systems and a 12 percent increase at Defense Systems. These increases were partially offset by $95 million of higher intercompany eliminations.
Year to Date
Year to date 2026 sales increased $1.6 billion, or 5 percent, driven by higher sales at all four sectors, including a 14 percent increase at Aeronautics
Systems. These increases were partially offset by $393 million of higher intercompany eliminations.
See “Segment Operating Results” below for further information by segment and “Product and Service Analysis” for product and service detail. See Note 10
to the financial statements for information regarding the company’s sales by customer type, contract type and geographic region for each of our segments.
-25-

-- 27 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Operating Income and Margin Rate
Current Quarter
Third quarter 2026 operating income increased $27 million, or 2 percent, primarily due to $68 million of higher segment operating income, partially offset
by a $52 million decrease in the FAS/CAS operating adjustment. Operating margin rate declined to 11.4 percent from 11.9 percent principally due to the
decrease in the FAS/CAS operating adjustment.
Third quarter 2026 G&A costs as a percentage of sales increased to 9.7 percent from 9.5 percent in the prior year period primarily due to an increase in our
investments for future business opportunities, partially offset by higher sales.
Year to Date
Year to date 2026 operating income increased $114 million, or 4 percent, primarily due to $511 million of higher segment operating income largely driven
by the prior year B-21 loss provision at Aeronautics Systems, partially offset by the prior year $231 million gain on the training services divestiture and a
$164 million decrease in the FAS/CAS operating adjustment. Operating margin rate declined to 10.5 percent from 10.7 percent primarily due to the prior
year gain on the training services divestiture and the decrease in the FAS/CAS operating adjustment, partially offset by a higher segment operating margin
rate.
Year to date 2026 G&A costs as a percentage of sales decreased to 9.7 percent from 9.9 percent in the prior year period primarily due to higher sales.
See “Segment Operating Results” below for further information by segment. For information regarding product and service operating costs and expenses,
see “Product and Service Analysis” below.
Federal and Foreign Income Taxes
Current Quarter
Third quarter 2026 income tax expense decreased $49 million, or 22 percent, due to a lower ETR and $25 million of lower earnings before income taxes.
The third quarter 2026 ETR decreased to 13.4 percent from 16.9 percent principally due to higher research credits.
Year to Date
Year to date 2026 income tax expense decreased $170 million, or 30 percent, due to a lower ETR, partially offset by $168 million of higher earnings before
income taxes. The year to date 2026 ETR decreased to 11.5 percent from 17.2 percent primarily due to the remeasurement of unrecognized tax benefits
during the second quarter of 2026 given recent developments with the IRS towards resolving our previously filed federal income tax returns and refund
claims, as well as higher research credits, including a benefit related to CAMT guidance recently issued by the IRS.
See Note 4 to the financial statements for additional information.
Net Earnings
Current Quarter
Third quarter 2026 net earnings increased $24 million, or 2 percent, primarily due to a $49 million decrease in income tax expense, a $31 million increase
in the non-operating FAS pension benefit and a $27 million increase in operating income, partially offset by an $86 million decrease in Other, net largely
driven by favorable returns on marketable securities in the prior year.
Year to Date
Year to date 2026 net earnings increased $338 million, or 12 percent, primarily due to a $170 million decrease in income tax expense, a $114 million
increase in operating income and a $96 million increase in the non-operating FAS pension benefit, partially offset by a $51 million decrease in Other, net
largely driven by lower favorable returns on marketable securities.
Diluted Earnings Per Share
Current Quarter
Third quarter 2026 diluted earnings per share increased $0.22, or 3 percent, reflecting a 2 percent increase in net earnings and a 1 percent reduction in
weighted-average diluted shares outstanding.
Year to Date
Year to date 2026 diluted earnings per share increased $2.60, or 14 percent, reflecting a 12 percent increase in net earnings and a 1 percent reduction in
weighted-average diluted shares outstanding.
-26-

-- 28 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
SEGMENT OPERATING RESULTS
Basis of Presentation
The company is aligned in four operating sectors, which also comprise our reportable segments: Aeronautics Systems, Defense Systems, Mission Systems
and Space Systems.
For purposes of the operating results discussion below, we assess our performance using certain financial measures that are not calculated in accordance
with GAAP.
Organic Sales
In the operating results discussion below, we present the performance of our Defense Systems sector using organic sales, a financial measure that is not
calculated in accordance with GAAP. Organic sales is defined as total sales excluding sales attributable to the company's former training services business.
This measure may be useful to investors and other users of our financial statements as a supplemental measure in evaluating the company’s underlying
sales growth as well as in understanding our ongoing business and future sales trends by presenting the company’s sales adjusted for the impact of the
divestiture. We reconcile this non-GAAP financial measure to its most directly comparable GAAP financial measure below. This non-GAAP measure may
not be defined and calculated by other companies in the same manner and should not be considered in isolation or as an alternative to operating results
presented in accordance with GAAP.
Segment Operating Income and Margin Rate
Segment operating income, as reconciled in the table below, and segment operating margin rate (segment operating income divided by sales) are non-
GAAP measures that reflect the combined operating income of our four segments less the operating income associated with intersegment sales. Segment
operating income includes pension expense allocated to our sectors under FAR and CAS and excludes FAS pension service expense and unallocated
corporate items (certain corporate-level expenses, which are not considered allowable or allocable under applicable FAR and CAS requirements, and costs
not considered part of management’s evaluation of segment operating performance). These non-GAAP measures may be useful to investors and other users
of our financial statements as supplemental measures in evaluating the financial performance and operational trends of our sectors. These measures may not
be defined and calculated by other companies in the same manner and should not be considered in isolation or as alternatives to operating results presented
in accordance with GAAP.
Three Months Ended September
30 	%
Nine Months Ended September
30 	%
$ in millions 	2026 	2025 	Change 	2026 	2025 	Change
Operating income 	$ 	1,269 	$ 	1,242 	2 % $ 	3,354 	$ 	3,240 	4 %
Operating margin rate 	11.4 % 	11.9 % 	10.5 % 	10.7 %
Reconciliation to segment operating income:
CAS pension expense 	(68) 	(122) 	(44)% 	(188) 	(356) 	(47)%
FAS pension service expense 	53 	55 	(4)% 	159 	163 	(2)%
FAS/CAS operating adjustment 	(15) 	(67) 	(78)% 	(29) 	(193) 	(85)%
Gain on sale of training services business 	— 	— 	NM 	— 	(231) 	NM
Training services divestiture – unallowable state
taxes and transaction costs 	— 	— 	NM 	— 	20 	NM
Intangible asset amortization and PP&E step-up
depreciation 	13 	21 	(38)% 	51 	63 	(19)%
Other unallocated corporate expense 	78 	81 	(4)% 	199 	165 	21 %
Unallocated corporate expense 	91 	102 	(11)% 	250 	17 	1,371 %
Segment operating income 	$ 	1,345 	$ 	1,277 	5 % $ 	3,575 	$ 	3,064 	17 %
Segment operating margin rate 	12.1 % 	12.3 % 	11.2 % 	10.1 %
-27-

-- 29 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Current Quarter
Third quarter 2026 segment operating income increased $68 million, or 5 percent, primarily due to $72 million of higher operating income at Aeronautics
Systems. Third quarter 2026 segment operating margin rate of 12.1 percent reflects strong program performance and higher operating margin rates at
Aeronautics Systems and Space Systems. Segment operating margin rate decreased from 12.3 percent in the third quarter of 2025 principally due to a prior
year $68 million favorable EAC adjustment in the restricted advanced microelectronics portfolio at Mission Systems.
Year to Date
Year to date 2026 segment operating income increased $511 million, or 17 percent, primarily due to $601 million of higher operating income at
Aeronautics Systems and $117 million of higher operating income at Mission Systems, partially offset by $78 million of lower operating income at Space
Systems and $76 million of lower operating income at Defense Systems. Segment operating margin rate increased to 11.2 percent from 10.1 percent
primarily due to a higher operating margin rate at Aeronautics Systems and Mission Systems, partially offset by a lower operating margin rate at Defense
Systems and Space Systems.
FAS/CAS Operating Adjustment
The third quarter 2026 and year to date 2026 FAS/CAS operating adjustment reflects lower CAS pension expense largely driven by favorable plan asset
returns in prior years.
Unallocated Corporate Expense
Current Quarter
The decrease in third quarter 2026 unallocated corporate expense is primarily driven by lower intangible asset amortization and PP&E step-up depreciation.
Year to Date
The increase in year to date 2026 unallocated corporate expense is primarily due to the prior year $231 million gain on the training services divestiture.
Net EAC Adjustments - We record changes in estimated contract earnings at completion (net EAC adjustments) using the cumulative catch-up method of
accounting. Net EAC adjustments can have a significant effect on segment operating income and margin rate.
The aggregate favorable and unfavorable EAC adjustments are presented in the table below:
Three Months Ended
September 30 Nine Months Ended September
30
$ in millions 	2026 	2025 	2026 	2025
Favorable EAC adjustments 	$ 	482 $ 	433 $ 	1,707 $ 	1,161
Unfavorable EAC adjustments 	(261) 	(352) 	(1,472) 	(1,054)
Net EAC adjustments 	$ 	221 $ 	81 $ 	235 $ 	107
Net EAC adjustments by segment are presented in the table below:
Three Months Ended
September 30 Nine Months Ended September
30
$ in millions 	2026 	2025 	2026 	2025
Aeronautics Systems 	$ 	124 $ 	(66) $ 	174 $ 	(225)
Defense Systems 	34 	35 	9 	141
Mission Systems 	92 	121 	212 	163
Space Systems 	(15) 	(5) 	(144) 	37
Eliminations 	(14) 	(4) 	(16) 	(9)
Net EAC adjustments 	$ 	221 $ 	81 $ 	235 $ 	107
-28-

-- 30 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
AERONAUTICS SYSTEMS 	Three Months Ended
September 30 	% 	Nine Months Ended September 30 	%
$ in millions 	2026 	2025 	Change 	2026 	2025 	Change
Sales 	$ 	3,575 	$ 	3,142 	14 % $ 	10,377 	$ 	9,070 	14 %
Operating income 	377 	305 	24 % 	1,044 	443 	136 %
Operating margin rate 	10.5 % 	9.7 % 	10.1 % 	4.9 %
Sales
Current Quarter
Third quarter 2026 sales increased $433 million, or 14 percent, primarily due to a $195 million increase on F-35 driven by the timing of material costs on
production lots and increased sustainment volume, higher B-21 sales and an increase in B-2 sustainment volume.
Year to Date
Year to date 2026 sales increased $1.3 billion, or 14 percent, primarily due to higher sales on B-21 and other restricted programs, a $237 million increase
on the E-130J TACAMO (“TACAMO”) program as it ramps up, a $229 million increase on F-35, and $116 million of higher B-2 sustainment volume. The
higher B-21 sales reflect the company’s first quarter 2026 agreement with the U.S. Air Force to expand production capacity and increase the aircraft
production rate, including the sale of a company-owned test asset. The sales increases were partially offset by a decrease on F/A-18 as final production
deliveries have completed.
Operating Income
Current Quarter
Third quarter 2026 operating income increased $72 million, or 24 percent, due to higher sales and a higher operating margin rate. Operating margin rate
increased to 10.5 percent from 9.7 percent primarily due to higher net contract margin adjustments, including on certain mature production and sustainment
programs.
Year to Date
Year to date 2026 operating income increased $601 million, or 136 percent, due to a higher operating margin rate and higher sales. Year to date 2026
operating margin rate of 10.1 percent reflects strong performance on certain mature production and sustainment programs. Operating margin rate increased
from 4.9 percent in 2025 primarily due to the absence of the prior year B-21 loss provision.
DEFENSE SYSTEMS 	Three Months Ended September
30 	% 	Nine Months Ended September 30 	%
$ in millions 	2026 	2025 	Change 	2026 	2025 	Change
Sales 	$ 	2,307 	$ 	2,059 	12 % $ 	6,299 	$ 	5,855 	8 %
Less: Training services sales 	— 	— 	— 	(112)
Organic sales 	$ 	2,307 	$ 	2,059 	12 % $ 	6,299 	$ 	5,743 	10 %
Operating income 	$ 	250 	$ 	234 	7 % $ 	590 	$ 	666 	(11)%
Operating margin rate 	10.8 % 	11.4 % 	9.4 % 	11.4 %
Sales
Current Quarter
Third quarter 2026 sales increased $248 million, or 12 percent, primarily due to a $180 million increase on Sentinel as the program continues to ramp,
higher volume on the Guided Multiple Launch Rocket System Extended Range (GMLRS ER) program due to the timing of awards, and higher volume on
various tactical solid rocket motor programs. These increases were partially offset by lower volume on armament programs, primarily on certain military
ammunition programs.
Year to Date
Year to date 2026 sales increased $444 million, or 8 percent, primarily due to a $356 million increase on Sentinel as the program continues to ramp, a $114
million increase on various tactical solid rocket motor programs, and higher volume across the IBCS portfolio. These increases were partially offset by a
$112 million reduction in sales related to the divested training services business and a $109 million decrease on armament programs, including certain
military ammunition programs.
-29-

-- 31 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Operating Income
Current Quarter
Third quarter 2026 operating income increased $16 million, or 7 percent, primarily due to higher sales, partially offset by a lower operating margin rate.
Operating margin rate decreased to 10.8 percent from 11.4 percent, primarily due to changes in contract mix toward more cost-type content.
Year to Date
Year to date 2026 operating income decreased $76 million, or 11 percent, primarily due to a lower operating margin rate, partially offset by higher sales.
Operating margin rate decreased to 9.4 percent from 11.4 percent principally due to lower net EAC adjustments, largely due to the Q2 2026 unfavorable
EAC adjustment on the Stand-in Attack Weapon (SiAW) program and the absence of a prior year favorable EAC adjustment on the EMD phase of the
Sentinel program.
MISSION SYSTEMS 	Three Months Ended September
30 	% 	Nine Months Ended September 30 	%
$ in millions 	2026 	2025 	Change 	2026 	2025 	Change
Sales 	$ 	3,155 	$ 	3,093 	2 % $ 	9,266 	$ 	9,057 	2 %
Operating income 	500 	515 	(3)% 	1,434 	1,317 	9 %
Operating margin rate 	15.8 % 	16.7 % 	15.5 % 	14.5 %
Sales
Current Quarter
Third quarter 2026 sales increased $62 million, or 2 percent, primarily due to ramp-up on restricted airborne radar programs and higher volume on marine
systems programs. These increases were partially offset by lower volume on restricted advanced microelectronics programs.
Year to Date
Year to date 2026 sales increased $209 million, or 2 percent, primarily due to ramp-up on restricted airborne radar programs, higher sales of $255 million
on marine systems programs, and the timing of materials on F-35. These increases were partially offset by lower volume on restricted advanced
microelectronics programs and a $129 million decrease on the Scalable Agile Beam Radar program.
Operating Income
Current Quarter
Third quarter 2026 operating income decreased $15 million, or 3 percent, primarily due to a lower operating margin rate, partially offset by higher sales.
Third quarter 2026 operating margin rate of 15.8 percent reflects strong program performance on marine systems and restricted airborne radar programs.
Operating margin rate decreased from 16.7 percent in the third quarter of 2025 due, in part, to a prior year $68 million favorable EAC adjustment in the
restricted advanced microelectronics portfolio.
Year to Date
Year to date 2026 operating income increased $117 million, or 9 percent, due to a higher operating margin rate and higher sales. Operating margin rate
increased to 15.5 percent from 14.5 percent, primarily due to higher net EAC adjustments driven by improved performance, as well as prior year
investments made by the sector in connection with restricted business opportunities.
SPACE SYSTEMS 	Three Months Ended September
30 	% 	Nine Months Ended September 30 	%
$ in millions 	2026 	2025 	Change 	2026 	2025 	Change
Sales 	$ 	2,749 	$ 	2,698 	2 % $ 	7,982 	$ 	7,912 	1 %
Operating income 	312 	298 	5 % 	783 	861 	(9)%
Operating margin rate 	11.3 % 	11.0 % 	9.8 % 	10.9 %
Sales
Current Quarter
Third quarter 2026 sales increased $51 million, or 2 percent, primarily due to ramp-up of programs in the restricted space portfolio, partially offset by $136
million of lower sales on Commercial Resupply Service missions due to launch timing.
-30-

-- 32 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Year to Date
Year to date 2026 sales increased $70 million, or 1 percent, primarily due to ramp-up of programs in the restricted space portfolio, $141 million of higher
intercompany sales in support of Sentinel, and $107 million of higher GPI sales. These increases were partially offset by a $159 million decrease on the
Graphite Epoxy Motor (GEM) 63XL program and a $129 million decrease on the Next-Generation Overhead Persistent Infrared Polar program.
Operating Income
Current Quarter
Third quarter 2026 operating income increased $14 million, or 5 percent, due to a higher operating margin rate and higher sales. Operating margin rate
increased to 11.3 percent from 11.0 percent, primarily due to changes in contract mix toward more fixed-price content.
Year to Date
Year to date 2026 operating income decreased $78 million, or 9 percent, primarily due to a lower operating margin rate, partially offset by higher sales.
Operating margin rate decreased to 9.8 percent from 10.9 percent, largely due to lower net EAC adjustments, partially offset by changes in contract mix
toward more fixed-price content.
PRODUCT AND SERVICE ANALYSIS
The following table presents product and service sales and operating costs and expenses by segment:
Three Months Ended September 30 	Nine Months Ended September 30
$ in millions 	2026 	2025 	2026 	2025
Segment Information: 	Sales
Operating
Costs and
Expenses 	Sales
Operating
Costs and
Expenses 	Sales
Operating
Costs and
Expenses 	Sales
Operating
Costs and
Expenses
Aeronautics Systems
Product 	$ 	2,736 $ 	2,463 $ 2,296 $ 	2,108 $ 	7,870 $ 	7,180 $ 6,715 $ 	6,575
Service 	798 	698 	804 	690 	2,391 	2,048 	2,234 	1,940
Intersegment eliminations 	41 	37 	42 	39 	116 	105 	121 	112
Total Aeronautics Systems 	3,575 	3,198 	3,142 	2,837 	10,377 	9,333 	9,070 	8,627
Defense Systems
Product 	1,920 	1,717 	1,657 	1,483 	5,129 	4,668 	4,639 	4,117
Service 	328 	287 	351 	297 	1,004 	893 	1,067 	940
Intersegment eliminations 	59 	53 	51 	45 	166 	148 	149 	132
Total Defense Systems 	2,307 	2,057 	2,059 	1,825 	6,299 	5,709 	5,855 	5,189
Mission Systems
Product 	2,230 	1,895 	2,203 	1,825 	6,446 	5,477 	6,398 	5,500
Service 	539 	440 	551 	466 	1,585 	1,312 	1,644 	1,383
Intersegment eliminations 	386 	320 	339 	287 	1,235 	1,043 	1,015 	857
Total Mission Systems 	3,155 	2,655 	3,093 	2,578 	9,266 	7,832 	9,057 	7,740
Space Systems
Product 	2,212 	1,956 	2,213 	1,980 	6,419 	5,817 	6,396 	5,702
Service 	359 	321 	348 	297 	1,035 	909 	1,149 	1,021
Intersegment eliminations 	178 	160 	137 	123 	528 	473 	367 	328
Total Space Systems 	2,749 	2,437 	2,698 	2,400 	7,982 	7,199 	7,912 	7,051
Segment Totals
Total Product 	$ 	9,098 $ 	8,031 $ 8,369 $ 	7,396 $ 25,864 $ 	23,142 $ 24,148 $ 	21,894
Total Service 	2,024 	1,746 	2,054 	1,750 	6,015 	5,162 	6,094 	5,284
Total Segment 	$ 11,122 $ 	9,777 $ 10,423 $ 	9,146 $ 31,879 $ 	28,304 $ 30,242 $ 	27,178
A reconciliation of segment operating income to total operating income is included in “Segment Operating Results.”
(1)
(1)
-31-

-- 33 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Product Sales and Costs
Current Quarter
Third quarter 2026 product sales increased $729 million, or 9 percent, primarily due to higher sales on F-35, B-21 and TACAMO at Aeronautics Systems
and higher volume on Sentinel, GMLRS ER, and tactical solid rocket motor programs at Defense Systems.
Third quarter 2026 product costs increased $635 million, or 9 percent, consistent with the higher product sales described above.
Year to Date
Year to date 2026 product sales increased $1.7 billion, or 7 percent, primarily due to higher sales on B-21, TACAMO and F-35 at Aeronautics Systems and
higher volume on Sentinel, tactical solid rocket motor programs and across the IBCS portfolio at Defense Systems.
Year to date 2026 product costs increased $1.2 billion, or 6 percent, reflecting a higher operating margin rate principally due to the absence of the prior year
B-21 loss provision at Aeronautics Systems.
Service Sales and Costs
Current Quarter
Third quarter 2026 service sales decreased $30 million, or 1 percent, primarily due to completion of the Special Electronic Mission Aircraft program at
Defense Systems in the prior year.
Third quarter 2026 service costs were comparable with the prior year period.
Year to Date
Year to date 2026 service sales decreased $79 million, or 1 percent, primarily due to lower restricted service sales at Space Systems, lower service volume
at Defense Systems due to the training services divestiture, and lower volume on airborne electronic warfare programs at Mission Systems, partially offset
by higher restricted service sales at Aeronautics Systems.
Year to date 2026 service costs decreased $122 million, or 2 percent, reflecting a higher operating margin rate principally driven by higher net EAC
adjustments on service programs at Aeronautics Systems, Mission Systems and Space Systems.
BACKLOG
Backlog consisted of the following as of September 30, 2026 and December 31, 2025:
September 30, 2026 	December 31, 2025
$ in millions 	Funded 	Unfunded
Total
Backlog Total
Backlog % Change in
2026
Aeronautics Systems 	$ 	15,511 $ 	11,288 $ 	26,799 $ 	23,052 	16 %
Defense Systems 	10,294 	26,181 	36,475 	27,796 	31 %
Mission Systems 	14,442 	5,533 	19,975 	18,632 	7 %
Space Systems 	9,848 	16,500 	26,348 	26,201 	1 %
Total backlog 	$ 	50,095 $ 	59,502 $ 	109,597 $ 	95,681 	15 %
Third quarter and year to date 2026 net awards totaled $16.4 billion and $46.2 billion, respectively. Backlog totaled $109.6 billion. Significant third quarter
new awards include $4.6 billion for restricted programs (primarily at Aeronautics Systems, Space Systems, and Mission Systems), $2.0 billion for Sentinel,
$1.4 billion for Virginia Class submarines, $1.3 billion for F-35 at Aeronautics Systems, and $1.0 billion for E-2.
LIQUIDITY AND CAPITAL RESOURCES
We are focused on the efficient conversion of operating income into cash to provide for the company’s material cash requirements, including working
capital needs, satisfaction of contractual commitments, funding of our pension and OPB plans, investment in our business through capital expenditures, and
shareholder returns.
At September 30, 2026, we had $3.7 billion in cash and cash equivalents. We expect cash and cash equivalents and cash generated from operating
activities, supplemented by borrowings under credit facilities, commercial paper and/or in the capital markets, if needed, to be sufficient to provide
liquidity to the company in the short-term and long-
-32-

-- 34 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
term. The company has a five-year senior unsecured revolving credit facility in an aggregate principal amount of $3.0 billion, and in April 2026, we
renewed our one-year $500 million uncommitted credit facility. At September 30, 2026, there were no borrowings outstanding under these credit facilities.
Cash Flow Measures
In addition to our cash position, we consider various cash flow measures in capital deployment decision-making, including cash provided by operating
activities and adjusted free cash flow, a non-GAAP measure described in more detail below.
Operating Cash Flow
The table below summarizes key components of cash provided by operating activities:
Nine Months Ended September
30 	%
$ in millions 	2026 	2025 	Change
Net earnings 	$ 	3,093 $ 	2,755 	12 %
Changes in trade working capital 	(2,154) 	(2,437) 	(12)%
Other, net 	430 	542 	(21)%
Net cash provided by operating activities 	$ 	1,369 $ 	860 	59 %
Beginning in the fourth quarter of 2025, the company redefined trade working capital presented in this table to include accounts receivable, unbilled receivables,
inventoried costs, trade accounts payable and advance payments and billings in excess of costs incurred. Prior period amounts and disclosures have been recast to conform
to the current period presentation.
Year to date 2026 net cash provided by operating activities increased $509 million as compared with the same period in 2025, primarily due to lower net
cash tax payments.
Adjusted Free Cash Flow
Adjusted free cash flow, as reconciled in the table below, is a non-GAAP measure defined as net cash provided by or used in operating activities, less
capital expenditures, plus proceeds from the sale of equipment to a customer (not otherwise included in net cash provided by or used in operating activities)
and the after-tax impact of discretionary pension contributions. Adjusted free cash flow includes proceeds from the sale of equipment to a customer, if any,
as such proceeds were generated in a customer sales transaction. It also includes the after-tax impact of discretionary pension contributions, if any, for
consistency and comparability of financial performance. This measure may not be defined and calculated by other companies in the same manner. We use
adjusted free cash flow as a key factor in our planning for, and consideration of, acquisitions, the payment of dividends and stock repurchases. This non-
GAAP measure may be useful to investors and other users of our financial statements as a supplemental measure of our cash performance, but should not
be considered in isolation, as a measure of residual cash flow available for discretionary purposes, or as an alternative to operating cash flows presented in
accordance with GAAP. During the nine months ended September 30, 2026 and 2025, the company made no discretionary pension contributions.
The table below reconciles net cash provided by operating activities to adjusted free cash flow:
Nine Months Ended September
30 	%
$ in millions 	2026 	2025 	Change
Net cash provided by operating activities 	$ 	1,369 $ 	860 	59 %
Capital expenditures 	(775) 	(788) 	(2)%
Proceeds from sale of equipment to a customer 	371 	— 	NM
Adjusted free cash flow 	$ 	965 $ 	72 	1,240 %
Year to date 2026 adjusted free cash flow increased $893 million, or 1,240 percent, as compared with the same period in 2025, primarily due to higher net
cash from operating activities and proceeds received in connection with the sale of equipment to a customer.
(1)
(1)
-33-

-- 35 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Investing Cash Flow
Year to date 2026 net cash used in investing activities decreased $177 million, or 36 percent, as compared with the same period in 2025, principally due to
$371 million of proceeds from the sale of equipment to a customer and $107 million of proceeds from the sale of an investment, partially offset by
$333 million of proceeds from the training services divestiture in the prior year.
Financing Cash Flow
Year to date 2026 net cash used in financing activities decreased $1.1 billion, or 38 percent, as compared with the same period in 2025, primarily due to a
$1.1 billion decrease in share repurchases.
Credit Facilities, Commercial Paper and Financial Arrangements - See Note 7 to the financial statements for further information on our credit facilities,
commercial paper and our use of standby letters of credit and guarantees.
Share Repurchases - See Note 2 to the financial statements for further information on our share repurchase programs.
Long-term Debt - See Note 5 to the financial statements for further information.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
There have been no material changes to our critical accounting policies and estimates from those discussed in our 2025 Annual Report on Form 10-K.
ACCOUNTING STANDARDS UPDATES
See Note 1 to our financial statements for further information on accounting standards updates.
FORWARD-LOOKING STATEMENTS AND PROJECTIONS
This Form 10-Q and the information we are incorporating by reference contain statements that constitute “forward-looking statements” within the meaning
of the Private Securities Litigation Reform Act of 1995. Words such as “will,” “expect,” “anticipate,” “intend,” “may,” “could,” “should,” “plan,”
“project,” “forecast,” “believe,” “estimate,” “guidance,” “outlook,” “trends,” “goals” and similar expressions generally identify these forward-looking
statements. Forward-looking statements include, among other things, statements relating to our future financial condition, results of operations and/or cash
flows. Forward-looking statements are based upon assumptions, expectations, plans and projections that we believe to be reasonable when made, but which
may change over time. These statements are not guarantees of future performance and inherently involve a wide range of risks and uncertainties that are
difficult to predict. Specific risks that could cause actual results to differ materially from those expressed or implied in these forward-looking statements
include, but are not limited to, those identified and discussed more fully in the section entitled “Risk Factors” in our 2025 Annual Report on Form 10-K
and from time to time in our other filings with the SEC. They include:
Industry and Economic Risks
• our dependence on the U.S. government for a substantial portion of our business
• significant delays or reductions in appropriations and/or for our programs, and U.S. government funding and program support more broadly, including
as a result of a prolonged continuing resolution and/or government shutdown, and/or related to the global security environment or other global events
• significant delays or reductions in payments as a result of or related to a breach of the debt ceiling or a prolonged government shutdown
• the use of estimates when accounting for our contracts and the effect of contract cost growth and our efforts to recover or offset such costs and/or
changes in estimated contract costs and revenues, including as a result of inflationary pressures, labor shortages, supply chain challenges, changes in
trade policies and/or other macroeconomic factors, and risks related to management’s judgments and assumptions in estimating and/or projecting
contract revenue and performance which may be inaccurate
• increased competition within our markets and bid protests
• continued pressures from macroeconomic trends, including on costs, schedules, performance and ability to meet expectations
-34-

-- 36 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Legal and Regulatory Risks
• investigations, claims, disputes, enforcement actions, litigation (including criminal, civil and administrative) and/or other legal proceedings
• changes in procurement and other laws, SEC, DoW and other rules and regulations, including changes through executive orders, contract terms and
practices applicable to our industry, findings by the U.S. government as to our compliance with such requirements, more aggressive enforcement of
such requirements and changes in our customers’ business practices and preferences globally
• the improper conduct of employees, agents, subcontractors, suppliers, business partners or joint ventures in which we participate, including the impact
on our reputation and our ability to do business
• environmental matters, unforeseen environmental costs and government and third-party claims
• unanticipated changes in our tax provisions or exposure to additional tax liabilities
Business and Operational Risks
• cyber and other security threats or disruptions faced by us, our customers or our suppliers and other partners, including threats or disruptions from the
use of artificial intelligence models capable of exploiting vulnerabilities to conduct or enhance cyber attacks, and changes in related regulations
• the performance and viability of our subcontractors and suppliers and the availability and pricing of raw materials, critical minerals and metals,
chemicals, parts and components, particularly with inflationary pressures, increased costs, pricing changes, shortages in labor and financial resources,
supply chain disruptions, and extended material lead times
• our ability to attract and retain a qualified and talented workforce with the necessary security clearances to meet our performance obligations
• our exposure to additional risks as a result of our international business, including risks related to global security and strategic alliances, geopolitical
and economic factors, misconduct, suppliers, laws and regulations
• our ability to innovate, develop new products and technologies, progress and benefit from digital transformation and maintain technologies to meet the
needs of our customers
• natural disasters, epidemics, pandemics and similar outbreaks and other significant disruptions
• products and services we provide related to hazardous and high risk operations, including the production and use of such products, which subject us to
various environmental, regulatory, financial, reputational and other risks
• our ability appropriately to protect and exploit intellectual property rights
General and Other Risk Factors
• the adequacy and availability of, and ability to obtain, insurance coverage, customer indemnifications or other liability protections
• the future investment performance of plan assets, gains or losses associated with changes in valuation of marketable securities related to our non-
qualified benefit plans, changes in actuarial assumptions associated with our pension and other postretirement benefit plans and legislative or other
regulatory actions impacting our pension and postretirement benefit obligations
• changes in business conditions that could impact business investments and/or recorded goodwill or the value of other long-lived assets, and other
potential future liabilities
You are urged to consider the limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of forward-looking
statements. These forward-looking statements speak only as of the date this report is first filed or, in the case of any document incorporated by reference,
the date of that document. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by applicable law.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes to our market risks from those discussed in our 2025 Annual Report on Form 10-K.
-35-

-- 37 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Item 4. Controls and Procedures
DISCLOSURE CONTROLS AND PROCEDURES
Our principal executive officer (Chair, Chief Executive Officer and President) and principal financial officer (Corporate Vice President and Chief Financial
Officer) have evaluated the company’s disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Securities Exchange Act
of 1934 (the Exchange Act)) as of September 30, 2026, and have concluded that these controls and procedures are effective to ensure that information
required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the SEC’s rules and forms. These disclosure controls and procedures include, without limitation, controls and procedures designed to
ensure that information required to be disclosed in the reports that we file or submit is accumulated and communicated to management, including the
principal executive officer and the principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
During the three months ended September 30, 2026, no changes occurred in our internal control over financial reporting that materially affected, or are
reasonably likely to materially affect, our internal control over financial reporting.
-36-

-- 38 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
We have provided information about certain legal proceedings in which we are involved in Notes 6 and 7 to the financial statements.
We are a party to various investigations, lawsuits, arbitration, claims, enforcement actions and other legal proceedings, including government investigations
and claims, that arise in the ordinary course of our business. These types of matters could result in administrative, civil or criminal fines, penalties or other
sanctions (which terms include judgments or convictions and consent or other voluntary decrees or agreements); compensatory, treble or other damages;
non-monetary relief; or other liabilities. Government regulations provide that certain allegations against a contractor may lead to suspension or debarment
from future government contracts or suspension of export privileges for the company or one or more of its components. The nature of legal proceedings is
such that we cannot assure the outcome of any particular matter. For additional information on pending matters, please see Notes 6 and 7 to the financial
statements, and for further information on the risks we face from existing and future investigations, lawsuits, arbitration, claims, enforcement actions and
other legal proceedings, please see “Risk Factors” in our 2025 Annual Report on Form 10-K.
Consistent with SEC Regulation S-K Item 103, we have elected to disclose those environmental proceedings with a governmental entity as a party where
the company reasonably believes such proceeding would result in monetary sanctions, exclusive of interest and costs, of $1.0 million or more.
Item 1A. Risk Factors
For a discussion of our risk factors please see the section entitled “Risk Factors” in our 2025 Annual Report on Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The approximate dollar value of shares that may yet be purchased under the company’s share repurchase authorization is $2.5 billion as of September 30,
2026. We had no repurchases of common stock during the three months ended September 30, 2026.
Share repurchases take place from time to time, subject to market and regulatory conditions and management’s discretion, in the open market or in
privately negotiated transactions. The company retires its common stock upon repurchase.
See Note 2 to the financial statements for further information on our share repurchase programs.
Item 5. Other Information
Consistent with Item 408 of Regulation S-K, the following table reflects Rule 10b5-1 trading arrangements and non-Rule 10b5-1 trading arrangements (as
defined in Item 408) entered into by any director or officer (as defined in Rule 16a-1(f) of the Exchange Act) during the quarter ended September 30, 2026.
Name
(Title)
Type of Trading
Arrangement 	Date of Adoption 	Expiration Date of Trading Arrangement
Aggregate Number of
Securities to Be Purchased
or Sold
Mark A. Welsh III 	Rule 10b5-1
Trading
Arrangement
July 27, 2026 August 7, 2027 or such earlier date upon the
completion of all trades under the plan or the
occurrence of such other termination events as
specified in the plan.
Sale of 392 shares of
common stock	(Director)
-37-

-- 39 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
Item 6. Exhibits
*+10.1 2026 Market Stock Units Grant Agreement Specifying Terms and Conditions Applicable to 2026 Market Stock Units Granted to Kathy J.
Warden Under the 2024 Long-Term Incentive Stock Plan
*15 Letter from Independent Registered Public Accounting Firm
*31.1 Certification of Kathy J. Warden pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*31.2 Certification of John T. Greene pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
**32.1 Certification of Kathy J. Warden pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
**32.2 Certification of John T. Greene pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
*101 Northrop Grumman Corporation Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, formatted as inline XBRL
(Extensible Business Reporting Language): (i) the Cover Page, (ii) Condensed Consolidated Statements of Earnings and Comprehensive
Income, (iii) Condensed Consolidated Statements of Financial Position, (iv) Condensed Consolidated Statements of Cash Flows, (v)
Condensed Consolidated Statements of Changes in Shareholders’ Equity, (vi) Notes to Condensed Consolidated Financial Statements, and
(vii) Other Information. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the
Inline XBRL document.
*104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
+ Management contract or compensatory plan or arrangement
* Filed with this report
** Furnished with this report
-38-

-- 40 of 55 --

Table of Contents
NORTHROP GRUMMAN CORPORATION
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
NORTHROP GRUMMAN CORPORATION
(Registrant)
By: /s/ Michael A. Hardesty
Michael A. Hardesty
Corporate Vice President, Controller and
Chief Accounting Officer
(Principal Accounting Officer)
Date: October 19, 2026
-39-

-- 41 of 55 --

Exhibit 10.1
NORTHROP GRUMMAN CORPORATION
2026 MARKET STOCK UNITS GRANT AGREEMENT
This 2026 Market Stock Units Grant Agreement (“Agreement”) applies to certain “Market Stock Units” (“MSUs”) granted by Northrop Grumman
Corporation (the “Company”) in 2026 under its 2024 Long-Term Incentive Stock Plan. The date of grant of your MSU award and the target number of
MSUs applicable to your award are set forth in the letter from the Company announcing your MSU award (your “Grant Letter”) and are also reflected in
the electronic stock plan award recordkeeping system (“Stock Plan System”) maintained by the Company or its designee. This Agreement applies only
with respect to the 2026 MSU award under the Plan, and you are subject to this Agreement upon accepting your grant. You are referred to as the “Grantee”
with respect to your award. Capitalized terms are generally defined in Section 11 below if not otherwise defined herein.
Each MSU represents a right to receive one share of the Company’s Common Stock, or cash of equivalent value as provided herein, subject to
vesting as provided herein. The performance period applicable to your award is August 19, 2026 to December 31, 2031 (the “Performance Period”). The
target number of MSUs subject to your award is subject to adjustment as provided herein. The MSU award is subject to all of the terms and conditions set
forth in this Agreement, and is further subject to all of the terms and conditions of the Plan and any rules adopted by the Committee, as such rules are in
effect from time to time. If you do not formally accept your MSU award, by entering into this Agreement in accordance with the instructions and time limit
set forth in your Grant Letter, you will be deemed to have forfeited your MSU award.
CEO - MSU 2026 1

-- 42 of 55 --

1. Vesting; Payment of MSUs.
The MSUs are subject to the vesting and payment provisions
established by the Committee with respect to the Performance Period.
MSUs (and any Dividend Equivalents (as defined below)) that vest
based on such provisions will be paid as provided below.
1.1. Performance-Based Vesting of MSUs. Subject to Sections 2,
3, 4 and 6 below, the MSUs subject to the award shall vest and become
nonforfeitable based on the performance methodology established by
the Committee for the Performance Period. At the conclusion of the
Performance Period, the Committee shall apply the performance
methodology based on the change in the stock price over the
Performance Period to determine the percentage of target MSUs subject
to the award (if any) that have vested for the Performance Period (the
“Earnout Percentage”), and its determination of the Earnout Percentage
shall be conclusive and binding. Any MSUs (and related Dividend
Equivalents) subject to the award that are not vested as of the
conclusion of the Performance Period after giving effect to the
Committee’s determinations under this Section 1.1 shall terminate and
become null and void as of the last day of the Performance Period.
1.2. Payment of MSUs. The number of MSUs payable at the
conclusion of the Performance Period (“Vested MSUs”) shall be
determined by multiplying the Earnout Percentage by the target number
of MSUs subject to the award. The Vested MSUs and any MSUs that
vest and become payable pursuant to Section 2 or 6 may be paid out in
either an equivalent number of shares of Common Stock, or, in the
discretion of the Committee, in cash or in a combination of shares of
Common Stock and cash. In the event of a cash payment, the amount of
payment for each Vested MSU to be paid in cash will equal the Fair
Market Value (as defined below) of a share of Common Stock as of the
date the Committee determines the extent to which the applicable MSU
performance criteria have been achieved. Vested MSUs will be paid
within 60 days of the vesting date, but in no event later than March 15
of the year following the last day of the Performance Period.
1.3. Dividend Equivalents. The Grantee shall be entitled to
payment for Dividend Equivalents (if any) with respect to any Vested
MSUs and any MSUs that vest and become payable pursuant to Section
2 or 6. For purposes of this Agreement, “Dividend Equivalents” means
the aggregate amount of dividends paid by the Company on a number
of shares of Common Stock equivalent to the number of Vested MSUs
(or the number of MSUs that vest and become payable pursuant to
Section 2 or 6) during the period from the beginning
of the Performance Period until the date the Vested MSUs (or the MSUs
that vest and become payable pursuant to Section 2 or 6) are paid,
without interest or other adjustments to reflect the time value of money.
For these purposes, any Vested MSUs or MSUs that vest and become
payable pursuant to Section 2 or 6 in excess of the target number of
MSUs subject to the award shall be considered to have been granted at
the beginning of the Performance Period. Dividend Equivalents (if any)
will be paid at the same time as the Vested MSUs (or the MSUs that
vest and become payable pursuant to Section 2 or 6) to which they
relate are paid. Dividend Equivalents will be paid in cash.
2. Early Termination of Award; Termination of Employment.
2.1 General. The MSUs (and related Dividend Equivalents)
subject to the award shall terminate and become null and void prior to
the conclusion of the Performance Period if and when (a) the award
terminates in connection with a Change in Control pursuant to Section 6
below, or (b) except as provided below in this Section 2 and in Section
6, the Grantee ceases for any reason to be an employee of the Company
or one of its subsidiaries.
2.2 Termination of Employment Due to Retirement, Death or
Disability.
Retirement. If the Grantee ceases to be employed by the Company or
one of its subsidiaries due to the Grantee’s Retirement (as defined
below), the MSUs will remain outstanding and vest as if Grantee had
remained an employee for the full Performance Period. Payment of any
Vested MSUs (and related Dividend Equivalents) will not be
accelerated, and will remain subject to Sections 1.2 and 4 hereof.
Death or Disability. If the Grantee ceases to be employed by the
Company as a result of death or Disability (a) a pro-rata portion of the
MSUs (and related Dividend Equivalents), based on the number of
calendar days the Grantee was actually employed by the Company or
one of its subsidiaries during the Performance Period over the number
of calendar days in the Performance Period, will vest based on actual
performance over the portion of the Performance Period up to and
including the date of death or Disability (“Prorated MSUs”), and (b)
payment of the Prorated MSUs (and related Dividend Equivalents) that
vest pursuant to this Section 2.2 will be made within 60 days of the
Grantee’s death or Disability, but in no event later than March 15 of the
year following the date of the death or Disability. Any MSUs (and
related Dividend Equivalents) subject to the award that do not vest in
accordance with this Section 2.2 upon a termination of the Grantee’s
employment due to death or
CEO - MSU 2026 1

-- 43 of 55 --

Disability shall terminate immediately upon such termination of
employment.
2.3Other Terminations of Employment. Subject to Section 6.2,
all MSUs (and related Dividend Equivalents) subject to the award shall
terminate immediately upon a termination of the Grantee’s employment
for any reason other than due to the Grantee’s Retirement, death or
Disability.
2.4Leave of Absence. Unless the Committee otherwise provides
(at the time of the leave or otherwise), if the Grantee is granted a leave
of absence by the Company, the Grantee (a) shall not be deemed to have
incurred a termination of employment at the time such leave
commences for purposes of the award, and (b) shall be deemed to be
employed by the Company for the duration of such approved leave of
absence for purposes of the award. A termination of employment shall
be deemed to have occurred if the Grantee does not timely return to
active employment upon the expiration of such approved leave or if the
Grantee commences a leave that is not approved by the Company.
2.5Salary Continuation. Subject to Section 2.4 above, the term
“employment” as used herein means active employment by the
Company or one of its subsidiaries and salary continuation without
active employment (other than a leave of absence approved by the
Company that is covered by Section 2.4) will not, in and of itself,
constitute “employment” for purposes hereof (in the case of salary
continuation without active employment, the Grantee’s cessation of
active employee status shall, subject to Section 2.4, be deemed to be a
termination of “employment” for purposes hereof). Furthermore, salary
continuation will not, in and of itself, constitute a leave of absence
approved by the Company for purposes of the award.
2.6Continuance of Employment Required. Except as expressly
provided in Section 2.2, Section 2.4 and in Section 6, the vesting of the
MSUs (and related Dividend Equivalents) subject to the award requires
continued employment through the last day of the Performance Period
as a condition to the vesting of any portion of the award. Employment
for only a portion of the Performance Period, even if a substantial
portion, will not entitle the Grantee to any proportionate vesting or
avoid or mitigate a termination of rights and benefits upon or following
a termination of employment. Nothing contained in this Agreement, the
Grant Letter, the Stock Plan System, or the Plan constitutes an
employment commitment by the Company or any subsidiary, affects the
Grantee’s status (if the Grantee is otherwise an at-will employee) as an
employee at will who is subject to termination without cause, confers
upon the Grantee any right to continue in the employ of the Company
or any subsidiary, or interferes in any way with the right of the
Company or of any subsidiary to terminate such employment at any
time.
2.7Death. In the event of the Grantee’s death prior to the delivery
of shares or other payment with respect to any MSUs (and related
Dividend Equivalents) vested hereunder, the Grantee’s Successor shall
be entitled to any payments to which the Grantee would have been
entitled under this Agreement with respect to such MSUs.
3. 	Non-Transferability and Other Restrictions.
3.1Non-Transferability. The award, as well as the MSUs (and
related Dividend Equivalents) subject to the award, are non-transferable
and shall not be subject in any manner to sale, transfer, anticipation,
alienation, assignment, pledge, encumbrance or charge. The foregoing
transfer restrictions shall not apply to: (a) transfers to the Company; (b)
transfers to a Successor upon death; or (c) if the Grantee has suffered a
Disability, permitted transfers to his or her legal representative.
Notwithstanding the foregoing, the Company may honor any transfer
required pursuant to the terms of a court order in a divorce or similar
domestic relations matter to the extent that such transfer does not
adversely affect the Company’s ability to register the offer and sale of
the underlying shares on a Form S-8 Registration Statement and such
transfer is otherwise in compliance with all applicable legal, regulatory
and listing requirements.
3.2Forfeiture or Recoupment of Awards. If, prior to payment or
issuance of shares with respect to the award, Grantee’s employment is
terminated for Cause (or Grantee has engaged in misconduct that could
have resulted in Grantee’s termination of employment for Cause if
Grantee had remained an employee), the Company may reduce or
eliminate any payments or issuances of shares with respect to the
award. You agree to be bound by and fully comply with the Company’s
Policy Regarding the Recoupment of Certain Incentive Compensation
Payments filed as Exhibit 97 to the Company’s 10-K for the year ended
December 31, 2025 and as in effect from time to time (“Recoupment
Policy”). Any payments or issuances of shares with respect to the award
are subject to the Recoupment Policy, as well as any recoupment or
similar provisions of applicable law, and the Grantee shall promptly
make any reimbursement requested by the Board or Committee
pursuant to such policy or applicable law with respect to the award. The
Grantee agrees, by accepting the award, that the Company and its
affiliates may deduct from any amounts it may owe the Grantee from
time to time (such as wages or other compensation) any amounts the
2

-- 44 of 55 --

Grantee is required to reimburse the Company pursuant to such policy
or applicable law with respect to the award.
4. 	Post-Employment Conduct.
4.1Executive Leadership Team Contribution. You acknowledge
and agree that as a member of the Executive Leadership Team (“ELT”),
you are involved in managing the global operations of the Company,
incorporated in Delaware and headquartered in Virginia. You are
involved in the most sensitive and proprietary matters affecting the
Company, its subsidiaries, predecessors, and/or affiliates (collectively,
“Northrop Grumman”), including from a technical, strategic and
financial perspective, and are widely exposed to confidential, sensitive
and proprietary information concerning Northrop Grumman’s global
operations, at the headquarters and each of the operating sectors,
including in the areas of space systems, military aircraft, missile
defense, advanced weapons and long-range fires capabilities, mission
systems, networking and communications, strategic deterrence systems,
advanced computing, microelectronics and cyber, directly or indirectly
for U.S. and international government customers. Your job
responsibilities require that you have a primary office location in
Virginia and/or you spend substantial time at the corporate headquarters
in Virginia, among other things, attending ELT and other leadership
meetings, and managing operations and employees in Virginia. You
occupy one of the most senior executive positions in the Company and
have far-reaching access to highly confidential, valuable and sensitive
information, customer, vendor and employee relationships, intellectual
property, strategic and tactical plans, and financial information and
plans. The Company has a legitimate business interest in restricting
your ability to compete in the specific manner set forth below. The
Company has provided you this grant, subject to this Agreement and as
consideration for the restrictive covenants set forth in this Section 4;
provided that the provisions of Sections 4.2 and 4.3 in this Agreement
shall not apply where not permitted by applicable law.
4.2 Non-Competition. For a period of twelve (12) months from the
date of the termination of your employment for any reason
(“Termination”), you will not, directly or indirectly, oversee, control,
participate in, or support the design, operation, research, manufacture,
marketing, sale, or distribution of “Competitive Products and Services”.
For the purpose of this section, “Competitive Products and Services”
shall mean products or services that compete for resources with or are
an alternative or potential alternative to, the products sold or services
provided by Northrop Grumman,
including without limitation products and services in the areas of space
systems, military aircraft, missile defense, advanced weapons and long-
range fires capabilities, mission systems, networking and
communications, strategic deterrence systems, advanced computing,
microelectronics and cyber, directly or indirectly for U.S. and
international government customers..
4.3Non-Solicitation of Customers. For a period of eighteen (18)
months from your Termination, you shall not, directly or
indirectly, solicit any customer, supplier, or teammate of Northrop
Grumman with whom you engaged, or about whom you received
confidential, sensitive, or proprietary information, in the course of your
employment with Northrop Grumman, for purposes of providing
products or services in competition with Northrop Grumman. In the
case of a governmental, regulatory or administrative agency,
commission, department or other governmental authority, the customer
is determined by reference to the specific program offices or activities
for which Northrop Grumman provides goods or services.
4.4Non-Solicitation of Employees. For a period of twenty-four
(24) months from your Termination, you shall not, directly or indirectly,
solicit or offer to hire, any person who was, within a period of six
months prior to your Termination, employed by Northrop Grumman,
with whom you worked or about whom you received information in the
course of your employment with Northrop Grumman.
4.5Non-Disparagement. You will not issue or communicate any
statement, whether verbal or written, or take any other action that
disparages or may be interpreted to disparage the Company, its
products, services, officers, directors, or employees; provided that the
foregoing shall not apply to any truthful statements made in connection
with a legal process, including government investigation, or as
otherwise provided by law. For the avoidance of doubt, nothing
prohibits you from making any disclosures that are protected under the
whistleblower provisions of any applicable law, rule, or regulation.
4.6Exceptions. You may request an exception to the covenants in
Sections 4.2, 4.3, or 4.4 by making a written request to the Company’s
Chief Human Resources Officer, with such exceptions being considered
at the sole discretion of the Company and communicated in writing to
you.
4.7Reasonableness. You agree that the restrictions set forth in
Sections 4.2, 4.3, and 4.4 are (i) reasonable and necessary in all
respects, including duration, territory and scope of activity, in order to
protect the Company’s
3

-- 45 of 55 --

legitimate business interests, (ii) that the parties have attempted to limit
your right to compete only to the extent necessary to protect the
Company’s legitimate business interests, and (iii) that you will be able
to earn a livelihood without violating the restrictions in this section. It is
the intent of the parties that the provisions of this section shall be
enforced to the fullest extent permissible under applicable law.
However, if any portion of Section 4.2, 4.3, or 4.4 is deemed
unenforceable, the parties agree that a court or arbitrator may revise the
portion deemed unenforceable to the maximum extent possible to
achieve the objective of the parties, and the remainder of the section
shall remain in full force and effect.
4.8Remedies. If you violate any provision in Section 4.2, 4.3, 4.4,
and/or 4.5 of this section, the Company shall have the right to terminate
without payment to you any unvested and/or unpaid MSUs (and
associated Dividend Equivalents) and require that you immediately
deliver to the Company an amount in cash equal to the aggregate Fair
Market Value, determined as of the vesting and/or payment date of all
MSUs already received, including any Dividend Equivalents, within
one year prior to the breach. Further, you acknowledge and agree that a
breach of any of the provisions of this section will result in immediate,
irreparable, and continuing damage to the Company for which there is
no adequate remedy at law, and the Company will be entitled to
injunctive relief, a decree of specific performance, and other relief as
may be proper, including monetary damages, to the maximum extent
available and without any requirement to post bond.
5. Compliance with Laws; No Stockholder Rights Prior to
Issuance.
The Company’s obligation to make any payments or issue any
shares with respect to the award is subject to full compliance with all
then applicable requirements of law, the Securities and Exchange
Commission, or other regulatory agencies having jurisdiction over the
Company and its shares, and of any exchange upon which stock of the
Company may be listed. The Grantee shall not have the rights and
privileges of a stockholder, including without limitation the right to vote
or receive dividends (except as expressly provided in this Agreement
with respect to Dividend Equivalents), with respect to any shares which
may be issued in respect of the MSUs until the date appearing on the
certificate(s) for such shares (or, in the case of shares entered in book
entry form, the date that the shares are actually recorded in such form
for the benefit of the Grantee), if such shares become deliverable.
6. 	Adjustments; Change in Control.
6.1Adjustments. The MSUs, Dividend Equivalents, and the shares
subject to the award are subject to adjustment upon the occurrence of
events such as stock splits, stock dividends and other changes in
capitalization in accordance with Section 6(a) of the Plan. Any such
adjustment or determination not to make any adjustment shall be
conclusive and binding.
6.2Possible Acceleration on Change in Control. Notwithstanding
the provisions of Section 2 hereof, and further subject to the Company’s
ability to terminate the award as provided in Section 6.3 below, the
Grantee shall be entitled to vesting of the award as provided below in
the event of the Grantee’s termination of employment if at the time of
the termination, the termination occurs either within the Protected
Period corresponding to a Change in Control of the Company or within
twenty-four (24) calendar months following the date of a Change in
Control of the Company, and the Grantee’s employment by the
Company and its subsidiaries is involuntarily terminated by the
Company and its subsidiaries for reasons other than Cause or by the
Grantee for Good Reason.
In the event the Grantee is entitled to payment in accordance with
the foregoing provisions of this Section 6.2, then the Grantee will be
eligible for payment of a number of MSUs (and related Dividend
Equivalents) determined in accordance with the following formula: (a)
the Earnout Percentage determined in accordance with Section 1 but
calculated based on the greater of (i) performance for the portion of the
Performance Period ending on the last day of the month coinciding with
or immediately preceding the date of the termination of the Grantee’s
employment or (ii) target performance, multiplied by (b) the target
number of MSUs subject to the award. Payment of any amount due
under this Section 6.2 will be made within 60 days of the date of the
termination of Grantee’s employment, but in no event later than March
15 of the year following the Grantee’s termination of employment.
6.3Automatic Acceleration; Early Termination. If the Company
undergoes a Change in Control triggered by clause (iii) or (iv) of the
definition thereof and the Company is not the surviving entity and the
successor to the Company (if any) (or a Parent thereof) does not agree
in writing prior to the occurrence of the Change in Control to continue
and assume the award following the Change in Control, or if for any
other reason the award would not continue after the Change in Control,
then upon the Change in Control the Grantee shall be entitled to a
payment of the MSUs (and related Dividend Equivalents) as provided
below and the award shall terminate. Unless the Committee expressly
provides
th
4

-- 46 of 55 --

otherwise in the circumstances, no acceleration of vesting of the award
shall occur pursuant to this Section 6.3 in connection with a Change in
Control if either (a) the Company is the surviving entity, or (b) the
successor to the Company (if any) (or a Parent thereof) agrees in
writing prior to the Change in Control to assume the award. The
Committee may make adjustments pursuant to Section 6(a) of the Plan
and/or deem an acceleration of vesting of the award pursuant to this
Section 6.3 to occur sufficiently prior to an event if necessary or
deemed appropriate to permit the Grantee to realize the benefits
intended to be conveyed with respect to the shares underlying the
award; provided, however, that, the Committee may reinstate the
original terms of the award if the related event does not actually occur.
In the event the Grantee is entitled to a payment in accordance
with the foregoing provisions of this Section 6.3, then the Grantee will
be eligible for payment of a number of MSUs (and related Dividend
Equivalents) determined in accordance with the following formula: (a)
the Earnout Percentage determined in accordance with Section 1 but
calculated based on the greater of (i) performance for the portion of the
Performance Period ending on the date of the Change in Control of the
Company or (ii) target performance, multiplied by (b) the target number
of MSUs subject to the award. Payment of any amount due under this
Section 6.3 will be made within 60 days of the Change of Control, but
in no event later than March 15 of the year following the Change in
Control. In the event the Grantee is employed by the Company or a
subsidiary immediately prior to the Change in Control and is entitled to
payment in accordance with the foregoing provisions of this Section
6.3, then this Section 6.3 shall control as to the amount and timing of
the payment of the award notwithstanding anything in Section 2.2 or
6.2 to the contrary. In the event of the Grantee’s Retirement pursuant to
Section 2.2 prior to a Change in Control described in the first paragraph
of this Section 6.3 in which the award is to be terminated, the Earnout
Percentage shall no longer be based on the portion of the Performance
Period otherwise considered for purposes of Section 2.2 but shall
instead be calculated based on performance for the portion of the
Performance Period ending on the date of the Change in Control of the
Company.
7. Tax Matters.
7.1 Tax Withholding. The Company or the subsidiary which
employs the Grantee shall be entitled to require, as a condition of
making any payments or issuing any shares upon vesting of the MSUs
and related Dividend Equivalents, that the Grantee or other person
entitled to such shares or other payment pay the minimum sums
required to be withheld by federal, state, local or other applicable tax
law with respect to such
vesting or payment. Alternatively, the Company or such subsidiary, in
its discretion, may make such provisions for the withholding of taxes as
it deems appropriate (including, without limitation, withholding the
taxes due from compensation otherwise payable to the Grantee or
reducing the number of shares otherwise deliverable with respect to the
award (valued at their then Fair Market Value) by the amount necessary
to satisfy such statutory minimum withholding obligations).
7.2Transfer Taxes. The Company will pay all federal and state
transfer taxes, if any, and other fees and expenses in connection with the
issuance of shares in connection with the vesting of the MSUs.
7.3Compliance. This Agreement is designed to be exempt from
Code Section 409A, and the Committee shall administer and construe
the award in such a way as to be exempt from and to avoid adverse tax
consequences under Code Section 409A.
7.4Unfunded Arrangement. The right of the Grantee to receive
payment under the award shall be an unsecured contractual claim
against the Company. As such, neither the Grantee nor any Successor
shall have any rights in or against any specific assets of the Company
based on the award. Awards shall at all times be considered entirely
unfunded for tax purposes.
7.5Code Section 280G. Notwithstanding any other provision of
this Agreement to the contrary, in the event that any amounts payable to
you under this Agreement, either alone or together with amounts
payable pursuant to any other plan, program or arrangement (a)
constitute “parachute payments” within the meaning of Section 280G of
the Code, and (b) but for this Section 7.5 would be subject to the excise
tax imposed by Section 4999 of the Code or any comparable successor
provisions (the “Excise Tax”), then the vesting acceleration provided
under this Agreement, shall be either (i) provided to you in full, or (ii)
provided to you to such lesser extent that would result in no portion of
the payments so accelerated being subject to the Excise Tax, whichever
of the foregoing amounts, when taking into account applicable federal,
state, local and foreign income and employment taxes, the Excise Tax,
and any other applicable taxes, results in the receipt by you, on an after-
tax basis, of the greatest amount of benefits, notwithstanding that all or
some portion of such benefits may be subject to the Excise Tax. All
determinations required to be made under this Section 7.5 shall be made
by a registered public accounting firm selected by the Company, which
shall provide supporting calculations both to the Company and you no
later than the date of the applicable Change in Control. In the event that
any payments or benefits to the Grantee are to be reduced pursuant to
this Section 7.5, such payments and benefits shall be reduced
5

-- 47 of 55 --

such that the reduction of compensation to be provided to the Grantee
as a result of this Section 7.5 is minimized. In applying this principle,
the reduction shall be made in a manner consistent with the
requirements of Section 409A and where two economically equivalent
amounts are subject to reduction but payable at different times, such
amounts shall be reduced on a pro rata basis but not below zero.
8. 	Choice of Law; Venue; Arbitration.
This Agreement shall be governed by the laws of the State of
Delaware. You agree to be bound by and fully comply with Northrop
Grumman Manual USHR 2-32, Arbitration and Mediation (“USHR 2-
32”). Any cause of action or claim arising out of or related to the terms
and conditions applicable to this grant will be determined through final
and binding arbitration, in accordance with USHR 2-32, provided that
the prevailing party in the arbitration shall be entitled to receive from
the losing party reasonably incurred attorneys’ fees and costs. You and
the Company agree that any arbitration hearing and related proceedings
shall be convened and conducted in Falls Church, VA. If you or the
Company believes they require immediate relief to enforce or challenge
this Agreement, before arbitration is commenced or concluded, either
party may seek injunctive or other provisional equitable relief from a
state or federal court in the Commonwealth of Virginia. All court
actions or proceedings arising under this Agreement shall be heard in a
state or federal court in the Commonwealth of Virginia. The Company
and you hereby agree to the jurisdiction of the state and federal courts
in the Commonwealth of Virginia and waive any right to object to such
actions on grounds of venue, jurisdiction or convenience.
9. Committee Authority.
The Committee has the discretionary authority to determine any
questions as to the date when the Grantee’s employment terminated and
the cause of such termination and to interpret any provision of this
Agreement, the Grant Letter, the Stock Plan System, the Plan, and any
other applicable rules. Any action taken by, or inaction of, the
Committee relating to or pursuant to this Agreement, the Grant Letter,
the Stock Plan System, the Plan, or any other applicable rules shall be
within the absolute discretion of the Committee and shall be conclusive
and binding on all persons.
10. Plan; Amendment.
The MSUs (and related Dividend Equivalents) subject to the
award are governed by, and the Grantee’s rights are subject to, all of the
terms and conditions of the Plan and any other rules adopted by the
Committee, as
the foregoing may be amended from time to time. The Grantee shall
have no rights with respect to any amendment of this Agreement or the
Plan unless such amendment is in writing and signed by a duly
authorized officer of the Company. In the event of a conflict between
the provisions of the Grant Letter and/or the Stock Plan System and the
provisions of this Agreement and/or the Plan, the provisions of this
Agreement and/or the Plan, as applicable, shall control.
11. Definitions.
Whenever used in this Agreement, the following terms shall have
the meanings set forth below and, when the meaning is intended, the
initial letter of the word is capitalized:
“Board” means the Board of Directors of the Company.
“Cause” means the occurrence of either or both of the following:
(i) The Grantee’s conviction for committing an act of fraud,
embezzlement, theft, or other act constituting a felony (other
than traffic related offenses, as a result of vicarious liability, or
as a result of good faith actions as an officer of the Company);
or
(ii) Willful misconduct by the Grantee that causes financial or
reputational harm to the Company. However, no act, or failure
to act, on the Grantee’s part shall be considered “willful” unless
done, or omitted to be done, by the Grantee not in good faith
and without reasonable belief that his or her action or omission
was in the best interest of the Company.
“Change in Control” is used as defined in the Plan.
“Code” means the United States Internal Revenue Code of 1986,
as amended.
“Committee” means the Company’s Compensation and Human
Capital Committee or any successor committee appointed by the Board
to administer the Plan.
“Common Stock” means the Company’s common stock.
“Disability” means, with respect to a Grantee, that the Grantee: (i)
is unable to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment which can be
expected to result in death or can be expected to last for a continuous
6

-- 48 of 55 --

period of not less than twelve months; or (ii) is, by reason of any
medically determinable physical or mental impairment which can be
expected to result in death or can be expected to last for a continuous
period of not less than twelve months, receiving income replacement
benefits for a period of not less than three months under an accident and
health plan covering employees of the Grantee’s employer.
“Fair Market Value” is used as defined in the Plan; provided,
however, the Committee in determining such Fair Market Value for
purposes of the award may utilize such other exchange, market, or
listing as it deems appropriate.
“Good Reason” means, without the Grantee’s express written
consent, the occurrence of any one or more of the following:
(i) A material and substantial reduction in the nature or status of
the Grantee’s authorities or responsibilities (when such
authorities and/or responsibilities are viewed in the aggregate)
from their level in effect on the day immediately prior to the
start of the Protected Period, other than (A) an inadvertent act
that is remedied by the Company promptly after receipt of
notice thereof given by the Grantee, and/or (B) changes in the
nature or status of the Grantee’s authorities or responsibilities
that, in the aggregate, would generally be viewed by a
nationally-recognized executive placement firm as resulting in
the Grantee having not materially and substantially fewer
authorities and responsibilities (taking into consideration the
Company’s industry) when compared to the authorities and
responsibilities applicable to the position held by the Grantee
immediately prior to the start of the Protected Period. The
Company may retain a nationally-recognized executive
placement firm for purposes of making the determination
required by the preceding sentence and the written opinion of
the firm thus selected shall be conclusive as to this issue.
In addition, if the Grantee is a vice president, the Grantee’s loss of
vice-president status will constitute “Good Reason”; provided
that the loss of the title of “vice president” will not, in and of
itself, constitute Good Reason if the Grantee’s lack of a vice
president title is generally consistent with the manner in which
the title of vice president is used within the Grantee’s business
unit or if the loss of the title is the result of a promotion to a
higher level office. For the purposes of the preceding sentence,
the Grantee’s
lack of a vice-president title will only be considered generally
consistent with the manner in which such title is used if most
persons in the business unit with authorities, duties, and
responsibilities comparable to those of the Grantee immediately
prior to the commencement of the Protected Period do not have
the title of vice-president.
(ii) A material reduction by the Company in the Grantee’s
annualized rate of base salary as in effect on the first to occur of
the start of the Performance Period or the start of the Protected
Period, or as the same shall be increased from time to time.
(iii) A material reduction in the aggregate value of the Grantee’s
level of participation in any of the Company’s short and/or
long-term incentive compensation plans (excluding stock-based
incentive compensation plans), employee benefit or retirement
plans, or policies, practices, or arrangements in which the
Grantee participates immediately prior to the start of the
Protected Period provided; however, that a reduction in the
aggregate value shall not be deemed to be “Good Reason” if the
reduced value remains substantially consistent with the average
level of other employees who have positions commensurate
with the position held by the Grantee immediately prior to the
start of the Protected Period.
(iv) A material reduction in the Grantee’s aggregate level of
participation in the Company’s stock-based incentive
compensation plans from the level in effect immediately prior to
the start of the Protected Period; provided, however, that a
reduction in the aggregate level of participation shall not be
deemed to be “Good Reason” if the reduced level of
participation remains substantially consistent with the average
level of participation of other employees who have positions
commensurate with the position held by the Grantee
immediately prior to the start of the Protected Period.
(v) The Grantee is informed by the Company that his or her
principal place of employment for the Company will be
relocated to a location that is greater than fifty (50) miles away
from the Grantee’s principal place of employment for the
Company at the start of the corresponding Protected Period;
provided that, if the Company communicates an intended
effective date for such relocation, in no event shall Good
Reason exist
7

-- 49 of 55 --

pursuant to this clause (v) more than ninety (90) days before
such intended effective date.
The Grantee’s right to terminate employment for Good Reason
shall not be affected by the Grantee’s incapacity due to physical or
mental illness. The Grantee’s continued employment shall not constitute
a consent to, or a waiver of rights with respect to, any circumstances
constituting Good Reason herein.
“Parent” is used as defined in the Plan.
“Plan” means the Northrop Grumman 2024 Long-Term Incentive
Stock Plan, as it may be amended from time to time.
The “Protected Period” corresponding to a Change in Control of
the Company shall be a period of time determined in accordance with
the following:
(i) If the Change in Control is triggered by a tender offer for shares
of the Company’s stock or by the offeror’s acquisition of shares
pursuant to such a tender offer, the Protected Period shall
commence on the date of the initial tender offer and shall
continue through and including the date of the Change in
Control; provided that in no case will the Protected Period
commence earlier than the date that is six (6) months prior to
the Change in Control.
(ii) If the Change in Control is triggered by a merger,
consolidation, or reorganization of the Company with or
involving any other corporation, the Protected Period shall
commence on the date that serious and substantial discussions
first take place to effect the merger, consolidation, or
reorganization and shall continue through and including the date
of the Change in Control; provided that in no case will the
Protected Period commence earlier than the date that is six (6)
months prior to the Change in Control.
(iii) In the case of any Change in Control not described in clause
(i) or (ii) above, the Protected Period shall commence on the
date that is six (6) months prior to the Change in Control and
shall continue through and include the date of the Change in
Control.
“Retirement” means that the Grantee (i) terminates employment
after December 31, 2030 but before December 31, 2031 (other than in
connection with a termination by the Company or a subsidiary for
Cause); and (ii) has assisted the Board with the transition of Grantee’s
executive officer position to the satisfaction of
the Board, including a Board-approved CEO successor being in place.
“Successor” means the person acquiring a Grantee’s rights to a
grant under the Plan as a beneficiary designated in the Stock Plan
System, or if none, the Grantee’s estate.
8

-- 50 of 55 --

NORTHROP GRUMMAN CORPORATION
EXHIBIT 15
LETTER FROM INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
October 19, 2026
The Board of Directors and Shareholders of Northrop Grumman Corporation
Northrop Grumman Corporation
2980 Fairview Park Drive
Falls Church, Virginia 22042
We are aware that our report dated October 19, 2026, on our review of the interim financial information of Northrop Grumman Corporation and
subsidiaries appearing in this Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, is incorporated by reference in Registration
Statement Nos. 033-59815, 033-59853, 333-67266, 333-100179, 333-107734, 333-121104, 333-125120, 333-127317, 333-175798, 333-273482, and 333-
281008 on Form S-8, 333-295222 on Form S-3, and 333-264549 on Form S-4.
/s/ Deloitte & Touche LLP
McLean, Virginia

-- 51 of 55 --

NORTHROP GRUMMAN CORPORATION
EXHIBIT 31.1
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kathy J. Warden, certify that:
1. 	I have reviewed this report on Form 10-Q of Northrop Grumman Corporation (“company”);
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4. 	The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-
15(f)) for the company and have:
a. 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;
b. 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c. 	Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. 	Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the company's most
recent fiscal quarter (the company’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the company’s internal control over financial reporting; and
5. 	The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):
a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and
b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal
control over financial reporting.
Date: October 19, 2026
/s/ Kathy J. Warden
Kathy J. Warden
Chair, Chief Executive Officer and President

-- 52 of 55 --

NORTHROP GRUMMAN CORPORATION
EXHIBIT 31.2
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John T. Greene, certify that:
1. 	I have reviewed this report on Form 10-Q of Northrop Grumman Corporation (“company”);
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4. 	The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-
15(f)) for the company and have:
a. 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;
b. 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c. 	Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. 	Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the company's most
recent fiscal quarter (the company’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the company’s internal control over financial reporting; and
5. 	The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):
a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and
b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal
control over financial reporting.
Date: October 19, 2026
/s/ John T. Greene
John T. Greene
Corporate Vice President and Chief Financial Officer

-- 53 of 55 --

NORTHROP GRUMMAN CORPORATION
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Northrop Grumman Corporation (the “company”) on Form 10-Q for the period ended September 30, 2026, as
filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kathy J. Warden, Chair, Chief Executive Officer and President of
the company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) 	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) 	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
company.
Date: October 19, 2026
/s/ Kathy J. Warden
Kathy J. Warden
Chair, Chief Executive Officer and President

-- 54 of 55 --

NORTHROP GRUMMAN CORPORATION
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Northrop Grumman Corporation (the “company”) on Form 10-Q for the period ended September 30, 2026, as
filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John T. Greene, Corporate Vice President and Chief Financial
Officer of the company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) 	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) 	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
company.
Date: October 19, 2026
/s/ John T. Greene
John T. Greene
Corporate Vice President and Chief Financial Officer

-- 55 of 55 --